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Summary 
Transcription of ribosomal RNA by RNA polymerase (Pol) I initiates ribosome biogenesis 
and regulates eukaryotic cell growth. Obtaining the crystal structure of Pol I would improve 
our understanding of the enzymes regulation and its functional properties. It has therefore 
been a target of investigation over the past 10 years. Within this work, a number of strategies 
were pursued to obtain a novel Pol I crystal form that allows for solving a high-resolution 
structure. Purification of Pol I from the fission yeast Schizosaccharomyces pombe was 
established and its crystallization assayed for this purpose. For the baker’s yeast 
Saccharomyces cerevisiae, new strains were established, the fermentation and purification 
adapted and a new crystal form obtained. This allowed for solving the structure of the 590-
kilodalton (kDa) enzyme at a resolution of 2.8 Å. For phasing, intrinsically bound zinc atoms 
were used. An atomic model of Pol I was built and refined to an R-free factor of 21% with 
excellent stereochemistry. The model revealed all 14 subunits of the enzyme with exception 
of the tandem winged helix domain of subunit A49 and several unstructured surface residues. 
The structure shows differences to Pol II. The dimerization domain of the Pol-I-specific 
A49/A34.5 subcomplex is anchored on the polymerase by an elongated, well ordered, lysine-
rich tail. The Pol-I- and Pol-III-specific subunit complex AC40/AC19 is first described 
structurally. Furthermore, the C-terminal domain of subunit A12.2 is shown to resemble the 
fold and positioning of TFIIS, thereby explaining the intrinsic cleavage activity of Pol I. A 
novel ‘expander’ element occupies the DNA template site and stabilizes an expanded active 
centre cleft with an unwound bridge helix. A ‘connector’ element invades the cleft of an 
adjacent polymerase and stabilizes an inactive polymerase dimer. The connector and expander 
must detach during Pol I activation to enable transcription initiation and cleft contraction by 
convergent movement of the polymerase ‘core’ and ‘shelf’ modules. Conversion between an 
inactive expanded and an active contracted polymerase state may generally underlie 
transcription. Regulatory factors can modulate the core–shelf interface that includes a 
‘composite’ active site for RNA chain initiation, elongation, proofreading and termination. 
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1. Introduction 
1.1 General importance and composition of RNA polymerases 
Every cell needs to perform a series of metabolic processes in order to stay alive. Among 
them, the transcription of DNA into RNA plays a central role. This task is performed by 
DNA-dependent RNA polymerases (Pols). Whereas viruses and organelles use a single 
subunit polymerase, all other cell types have evolved one or more mutli-subunit polymerases1. 
In bacteria and archaea, one single polymerase transcribes all forms of RNA2,3. However, in 
eukaryotes, three different polymerases have evolved to perform specific tasks: (1) Pol I 
transcribes ribosomal RNA (rRNA); (2) Pol II produces messenger RNA (mRNA) and several 
small, functional RNAs; and (3) Pol III transcribes transfer RNA (tRNA), one small rRNA 
and others4. In plants, two additional polymerases (IV and V) exist and have a function in 
RNA interference and gene silencing5,6. The three general eukaryotic Pols share a common 
core of the five subunits Rpb5, Rpb6, Rpb8, Rpb10 and Rpb12. Furthermore, the large 
subunits are homologous: A190 and A135 in Pol I, Rpb1 and Rpb2 in Pol II and C160 and 
C128 in Pol III7. All Pols contain a protruding element that is called stalk and consists of two 
strongly associated subunits that have related counterparts: A14/A43 in Pol I8, Rpb4/Rpb7 in 
Pol II9 and C17/C25 in Pol III10. Additionally, the Pols include a heterodimeric subcomplex 
that is shared between Pol I and III (AC40/AC19) and homologous to Rpb3/Rpb11 in Pol II7. 
Apart from the 12 homologous, shared or common subunits, Pol I and III contain an 
additional subcomplex that consists of the two subunits A49/A34.5 or C37/C53, 
respectively11. Finally, the trimeric C82/C34/C31 subcomplex is unique to Pol III12. Table 1 
displays all subunits of the three eukaryotic polymerases and their relation to each other. 
Throughout this thesis, the nomenclature will refer to the yeast Saccharomyces cerevisiae and 
might differ from other organisms. 
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Table 1. Yeast RNA Polymerase Subunits and Homologues4. 
Pol II Pol I Pol III 
Polymerase Core 
Rpb1 A190 C160 
Rpb2 A135 C128 
Rpb3 AC40 AC40 
Rpb11 AC19 AC19 
Rpb9 AC12.2 N-ribbon C11 N-ribbon 
TFIIS C-ribbona AC12.2 C-ribbon C11 C-ribbon 
Rpb5 Rpb5 Rpb5 
Rpb6 Rpb6 Rpb6 
Rpb8 Rpb8 Rpb8 
Rpb10 Rpb10 Rpb10 
Rpb12 Rpb12 Rpb12 
Polymerase Stalk 
Rpb4 A14 C17 
Rpb7 A43 C25 
General Transcription Factors and Their Counterparts 
Tfg1 (TFIIFα) A49 (N-terminal domain) C37 
Tfg2 (TFIIFβ) A34.5 C53 
Tfa1 (TFIIEα)b  C82b 
Tfa2 (TFIIEβ)c A49 (C-terminal domain)c C34c 
  C31 
a TFIIS is a dissociable factor that is not part of the polymerase core. Its C-terminal 
ribbon domain (C ribbon) is however structurally and functionally related to the 
corresponding domains of A12.2 and C11. 
b These proteins share ‘‘extended’’ WH domains but their evolutionary relationship 
remains at present tentative. 
c These proteins share two subsequent WH domains but their evolutionary 
relationship remains at present tentative. 
 
1.2 The rDNA gene and its organization 
Apart from transcription of DNA into RNA, the translation of mRNA into proteins is another 
central cellular process that is common to all organisms. It is performed by ribosomes which 
themselves consist of RNA and proteins13. The large ribosomal subunit is termed 60S and 
contains the 24S, the 5.8S and the 5S rRNAs as well as 42 ribosomal proteins. The small 
subunit, called 40S, consists of the 18S rRNA and 32 additional proteins13. Biogenesis of 
ribosomes starts with processing of the 35S rRNA precursor which is produced by Pol I from 
multiple copies of the rDNA gene. From the 35S precursor, the three ribosomal RNAs 24S, 
18S and 5.8S are processed. The smallest rRNA (5S) is transcribed by Pol III14. 
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In quantitative terms, the production of rRNA is one of the most energy-consuming processes 
in the cell. It accounts for up to 60% of overall transcription rates and results in up to 80% of 
total RNA in exponentially growing cells15,16. The factories of rRNA transcription are the 
nucleoli, which are the most prominent substructure of the nucleus. Multiple copies of the 
rDNA gene (~150 in yeast) are located in the same genomic region and are, if they are active, 
each transcribed by several Pol I molecules. This results in the formation of “Christmas-tree-
like” structures that can be visualized by electron microscopy in so-called “Miller-spreads”17. 
Figure 1 displays a nucleolus as the most prominent substructure of the nucleus (a)18 as well 
as a Miller spread (b)17. In yeast, rDNA repeats are clustered at one single position on 
chromosome XII whereas human cells have five separate rDNA clusters19,20. Each of those 
clusters can form a nucleolus and is therefore termed nucleolar organizer region (NOR)21. All 
NORs share a conserved organization that is depicted in Figure 1c22: The rDNA genes are 
tandemly repeated and separated by an intergenic spacer (IGS) that plays a role in silencing. 
Each yeast repeat contains the 35S rRNA precursor gene, its promoter, an enhancer, a 
terminator, the Pol III transcribed 5S rRNA gene and elements that regulate replication22.  
 
 
Figure 1. The nucleolus and rDNA repeat organization. 
a Electron microscopic representation of a S. cerevisiae nucleolus18. FC, Fibrillar centre; DFC, Dense fibrillar 
centre; GC, Granular centre. b Miller spread of a Triturus viridescens oocyte displays rDNA transcription by 
multiple Pol I molecules resulting in a christmas-tree-like representation17. The bar corresponds to 1µm. c 
Schematic representation of the S. cerevisiae rDNA locus22. The position of the rDNA repeat cluster on 
chromosome XII including the left (L) and the right (R) flanking regions with respect to the centromere and 
telomere is shown. Each rDNA repeat consists of the Pol I-transcribed 35S rRNA gene (precursor for the 18S, 
5.8S, and 25S rRNAs) and the RNA Pol III-transcribed 5S rRNA gene. Arrows mark the transcription start sites 
and direction. The positions of three regulatory DNA elements ENH (enhancer), CP (core promoter), and UE 
(upstream element) are indicated. 
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1.3 Pol I transcription cycle 
In general, rDNA promoters are 140-160 base pair 
(bp) long stretches which are not well conserved 
throughout different organisms23. Nevertheless, all of 
them seem to contain two regulatory elements, the 
so-called upstream element (UE) and the core 
element (CE), as displayed in Figure 1 and Figure 2. 
The UE is bound by the upstream activation factor 
(UAF) that consists of Rrn5, Rrn9, Rrn10, UAF30 
and the associated histones H3 and H423. The UAF is 
then bound by the TATA binding protein (TBP) and 
the core factor (CF) which in turn interacts with the 
core element of the promoter24. CF is a heterotrimer 
that consists of the proteins Rrn6, Rrn7 and 
Rrn1125,26. Upon interaction of CF with the initiation 
factor Rrn3, Pol I is recruited27. It has been shown 
that this recruitment is dependent on the binding of 
Rrn3 to the Pol I stalk subunit A43 on the one hand, 
and an interaction with the CF component Rrn6 on 
 
 
Figure 2. Pol I initiation in yeast21,23,24. 
The Upstream Activating Factor (UAF) 
binds to the upstream element (UE) and 
recruits TBP (TATA binding protein) as 
well as the Core Factor (CF). Pol I (RP I) 
itself binds Rrn3 via its subunit A43 and is 
subsequently recruited to CF, partly by 
interaction of Rrn3 with Rrn6. 
the other hand27. Following initiation, Pol I starts transcribing and the initiation factors Rrn3, 
CF as well as TBP dissociate from the complex. The complete process of initiation is 
schematically depicted in Figure 223. 
Once in elongation mode, Pol I transcribes the complete 35S rRNA precursor. The Pol I 
elongation complex contains several components including a number of general Pol II 
elongation factors. It has been shown that the Spt4/5 complex can interact with Pol I and has a 
regulatory effect28,29. Additionally, the Paf1 complex has been shown to associate with 
elongating Pol I30. The Paf1 complex is associated with chromatin remodelling and was 
mainly studied in the Pol II system31. Recent work from this system deomstrated that the 
subunit Rtf1 of the Paf1 complex binds the C-terminal repeat (CTR) of Spt5 if this CTR 
carries a specific phosphorylation32,33. By homology, this strongly argues for elongating Pol I 
to be associated with both, the Paf1 complex as well as Spt4/5. Independently, a head-to-tail 
dimerization of elongating polymerases has been proposed from EM studies34. This would 
agree with the high loading rate of Pol I and might contribute to Rrn3 release. However, it is 
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unclear how backtracking and/or RNA cleavage would take place in such a scenario. 
Furthermore, a strain with Rrn3 fused to the C-terminus of A43 is still able to elongate at wild 
type levels. 
The termination of Pol I transcription has been a focus of numerous studies. Whereas a 61 bp 
T-rich sequence is sufficient to terminate Pol I in vivo, the involved players and their 
respective roles remain to be defined. In any case, the endonuclease Rnt1 as well as the 
exonuclease Rat1 and the helicase Sen1 seem to be involved35-37. The action of Rat1 in a 
“torpedo-like” fashion has been discussed but does not seem to be sufficient for termination in 
an in vitro system38. A binding site for the protein Reb1 has been found at the 3’ end of the 
25S rRNA sequence and is situated only 16 bp 5’ of the T-rich sequence39. Binding of the 
Reb1 homologue Nsi1 was suggested to slow down elongating Pol I before it hits the T-rich 
termination patch39. However, the rRNA precursor still needs to be cleaved off and released. 
Which nuclease performs this task or if the Pol I subunit A12.2 is involved in that process 
remains to be resolved. 
 
1.4 Regulation of Pol I activity 
Despite the presence of numerous rDNA copies, only half of them are actively transcribed at 
one point in time, even in exponentially growing cells40. The reason for rDNA gene 
inactivation can mostly be found in epigenetic silencing which is characterized by DNA 
hyper-methylation and deacetylation of histones (eg. H4)41. Additionally, silencing of rDNA 
genes in higher eukaryotes requires a transcript of the IGS which is incorporated into a 
nucleolar remodelling complex that subsequently associates with the IGS itself42. 
Independent of the epigenetic state of rDNA repeats and hence the number of active genes, 
Pol I loading rate seems to have a high importance in regulating rDNA transcription40. 
Meaning, Pol I activity can be regulated via the availability of Pol I / Rrn3 complexes since 
the formation of a stable complex of Pol I with Rrn3 was shown to be a prerequisite for 
efficient initiation43. Rrn3 binds to the Pol I stalk subunit A43 in a phosphorylation dependent 
manner27,44,45. Thus, one of the main mechanisms controlling Pol I activity is based on 
phosphorylation and dephosphorylation of Pol I subunits and Rrn3 itself45 and thereby the 
manipulation of available Pol I / Rrn3 complex. Rrn3 forms a homodimer in solution but 
binds Pol I as a monomer, for which it needs to be dephosphorylated44. In contrast, site 
specific Pol I phosphorylation is required for binding Rrn345,46. The two main Pol I 
phosphorylation sites cluster around the stalk46 and around A190 residue 141547. The 
 
 
18 
 
phosphorylation of those sites and hence the amount of Pol I / Rrn3 complex formation was 
shown to be dependent on signalling via the target of rapamycin (TOR) pathway48. The TOR 
pathway also links the production of rRNA to ribosomal protein transcription by Pol II49. In 
line with this, the level of Rrn3 is decreased by down-regulated expression coupled to targeted 
proteasomal degradation upon starvation-induced impairment of TOR signalling50. On the 
other hand, if the amount of Pol I / Rrn3 complex is artificially increased by a covalent fusion 
of Rrn3 to A43, regulation defects occur16. This further strengthens the role of Pol I / Rrn3 
complex number to be important for rRNA transcription regulation. 
Independent of Rrn3, an inactive dimeric form of Pol I was observed in yeast43,51. Similarly, a 
human version of Pol I was described to be inactive and is most likely dimeric as well52. To 
summarize, it is known that Pol I regulation takes place (1) at an epigenetic level, (2) via a 
phosphorylation-dependent influence on the abundance of Pol I / Rrn3 complexes, and (3) by 
changing the level of available Rrn3. A dimerization of Pol I does take place and might have 
an additional regulatory role. Also, further phosphorylations on Pol I subunits might have 
additional influences. However, none of these appear to account for rRNA expression changes 
on their own. It seems rather likely that a complex interplay occurs which orchestrates the 
efficient and tight regulation of rRNA transcription. Supporting the special requirement of 
tight regulation, it has been shown that deregulation of rRNA transcription in humans is 
largely observed in cancer cells and is correlated to tumour malignancy53,54. This also means, 
that Pol I - dependent transcription emerges as a novel target for cancer therapy54. The 
availability of a Pol I structure with atomic resolution would be the ideal starting point for 
designing specific inhibitors, comparable to the structure-based design of antibiotics 
influencing the bacterial RNA polymerase55,56. 
 
1.5 Structural information on DNA-dependent RNA polymerases and their general 
transcription factors 
At the beginning of this work, the structure of RNA polymerase II 10-subunit-core from yeast 
had been solved for a decade57,58 and the 12-subunit-structure was known9,59. Despite intense 
work on Pol I, the only available data on the complete polymerase originated from electron 
microscopy. This included a negative stain reconstruction from Patrick Schultz’s lab60 as well 
as a cryo EM map from our group8. In addition, the crystal structure of the heterodimeric 
stalk-subunit-complex A14/A43 has been reported8,61. Later on, the crystal structures of the 
Pol-specific subunit complex A49/A34.5 and the initiation factor Rrn3 were solved in our 
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lab44. Finally, the architecture of the complete 14-subunit Pol I has been further elucidated by 
lysine-lysine crosslinking coupled to mass spectrometry62. This did not only display the 
location of the A49/A34.5 subcomplex on the A135 lobe and the top of the cleft (not entirely 
complying with the cryo-EM8), but also showed that the C-terminus of A12.2 folds like the 
Pol II elongation and cleavage factor TFIIS. The TFIIS-like fold explains the strong intrinsic 
cleavage activity which Pol I exhibits in contrast to Pol II8. According to their structural and 
functional properties, domains were assigned to the different polymerase subunits58. Despite 
the notable differences between the three eukaryotic multi-subunit polymerases, most 
domains are apparently conserved8. Figure 3 displays the domain assignment for Pol II and 
the suspected Pol I homology, which largely originated from sequence analysis of all 
subunits8. In the case of A12.2, information regarding homology to TFIIS was added later on 
according to crosslinking/mass spectrometry results62. The sequence comparison shows that 
A190 contains the main elements of the Pol II subunit Rpb1. Most strikingly, it displays large 
insertions in the clamp head and the jaw domains, as well as a prominent deletion in the foot 
domain. Furthermore, Pol I does not contain the C-terminal domain (CTD) of Rpb1 with its 
regulatory, repetitive sequence elements8. A135 and Rpb2 are overall conserved, as are AC40 
and Rpb3 as well as AC19 and Rpb11. The latter two, however, display differences in their N- 
or C-terminal regions. 
 
 
 
Figure 3. Structure-guided sequence alignment8. 
Pol II structure-guided sequence alignment of five Pol I subunits with their homologs in Pol II. The domain 
organization of Pol II subunits Rpb1, Rpb2, Rpb3, Rpb11, and Rpb9 is shown as diagrams8. Insertions and 
deletions exceeding five amino acid residues are indicated. Conserved folds are indicated by orange highlighting 
of the bar above the diagrams. CTD: C-terminal domain. 
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The structure of the N-terminal so-called dimerization domain of A49 shows a strong 
homology to the dimerization domain of Tfg1 and Tfg2, subunits of the Pol II initiation factor 
TFIIF11,63. Furthermore, the A49 C-terminal tandem-winged helix (tWH) domain displays 
similarities with the winged helix domain of the Pol II initiation factor TFIIE11. Overall, the 
homologies between Pol I subunits and Pol II transcription factors seem quite striking but also 
make a lot of sense: While Pol II transcribes a larger number of different target genes, it 
requires a high variability in levels of regulation. In contrast, Pol I only needs to perform one 
single task and may well have perfectly adapted to it, including the permanent incorporation 
of transcription factors. Pol III exhibits some of the respective elements as well, and also 
contains an additional heterotrimeric subcomplex C82/C34/C31 that displays similarities to 
TFIIE64-66. 
In the past years, the development of novel structure and domain prediction algorithms such 
as “HHPred” by the Soeding group67 led to the discovery that the Core factor subunit Rrn7 
(TAF1B in humans), one of the main Pol I initiation factors, is homologous to the general Pol 
II initiation factor TFIIB68,69. The consistent discovery of homologies between Pol II 
transcription factors and Pol I subunits or initiation factors is a striking feature that confirms 
the close evolutionary relationship between all multi-subunit polymerases4. This suggests that, 
when working with Pol I, structural and functional features of other polymerases and their 
transcription factors should be studied and constantly considered. Figure 4 displays the crystal 
structures of 12-subunit RNA polymerase II from the yeasts S. cerevisiae70 and S. pombe71 as 
well as bacterial polymerase from Thermus aquaticus72 and the archeal polymerase from 
Sulfolobus solfataricus3,73. Pol I subunit crystal structures and EM reconstructions of the 
complete enzyme are displayed in Figure 5. Known crystal structures of Pol I subunits are the 
A14/A43 stalk subcomplex, the A49/A34.5 dimerization domain and the A49 C-terminal 
tandem winged helix domain. Solved crystal structures of Pol II transcription factors include 
TFIIB, TFIIS, the human TFIIF homologue as well as parts of TFIIE, TFIID and TFIIH. 
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Figure 4. Crystal structures of multi-subunit DNA-dependent RNA polymerases3,70-74. 
The crystal structures of eukaryotic Pol II from S. cerevisiae (1WCM)70 and S. pombe (3H0G)71 are displayed in 
front view. The bacterial polymerase from T. aquaticus (1I6V)72 and the archaeal polymerase from S. 
solfataricus (2WAQ)73 are displayed in back view (Figures modified from 74). The core and overall shape are 
conserved throughout evolution. Bacterial polymerase does not contain a stalk and organism- or polymerase-
specific subunits exist in all organisms. Subunit colour code as indicated. 
 
1.6 Scope of this study 
Solving the structure of Pol II at an atomic level led to a much more detailed and well-
founded understanding of transcription. Furthermore, it induced a boost of work targeted at 
specific polymerase features that were elucidated by the structure, giving the complete 
transcription field a significant boost. Since then, one focus of Patrick Cramer’s group was to 
solve the structure of another eukaryotic polymerase to validate, compare and deepen our 
understanding of transcription in general. Independently, its role as a major player in 
ribosome synthesis and its apparently well-defined structure made Pol I an appealing target. 
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Claus Dieter Kuhn was the first “Pol-I-PhD-student” who implicated a novel protocol for the 
large scale purification of S. cerevisiae Pol I in collaboration with the group of Herbert 
Tschochner in Regensburg. Claus succeeded in obtaining a cryo-EM map and elucidating the 
functional architecture of Pol I as well as in crystallizing the 14-subunit Pol I75. 
Unfortunately, it was never possible to solve the Pol I structure from the initial crystals due to 
a number of reasons, such as poor reproducibility, an extremely large unit cell and enormous 
radiation damage of the crystals during data collection, a high number of molecules in the 
 
 
Figure 5. Electron microscopy structures of the complete RNA polymerase I and known crystal structures 
of Pol I subunits8. 
a Cryo EM envelope of Pol I with fitted Pol II 10-subunit-core crystal structure8. The fit demonstrates that the 
overall shape is conserved between Pol I and Pol II. However, solvent exposed parts display significant 
differences. The position of the A49/A34.5 dimerization module is proposed to be outside the funnel domain 
(bottom left in the panel). b Negative stain EM reconstruction of Pol I60. Under specific conditions, Pol I forms a 
dimer which is characterized by interaction of the stalk from one polymerase with the cleft of another. The 
indicated bar corresponds to 10 nm. c Crystal structure of the S. cerevisiae Pol I stalk8. A43 (blue) and A14 (red) 
correspond to the Pol II subunits Rpb7 and Rpb4, respectively.  However, a domain swop seems to have taken 
place and the overall shape of the Pol I stalk is less bulky than the one of its Pol II counterpart. Upon limited 
proteolysis, flexible regions have been removed, including the C-terminal (presumably unstructured) region of 
A43 in order to improve crystallization behaviour61. d The structure of the A49/A34.5 (slate and pink, 
respectively; solved from the yeast Candida glabrata) dimerization domain is similar to the Tfg1/Tfg2 
dimerization domain of the Pol II initiation factor TFIIF11. Both engage in a double beta-barrel fold that results 
in a tight association of the two subunits. A34.5 contains an additional, charged C-terminal tail and A49 has a C-
terminal domain that is displayed in (e). e Crystal structure of the tandem winged helix domain (tWH) situated at 
the C-terminus of A4911. By structural and functional homology, it likely is related to the winged helix domain 
of the Pol II initiation factor TFIIE. 
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asymmetric unit and difficulties with phasing. Therefore, a second PhD student, Stefan 
Jennebach, took over the project and continued to work on Pol I crystallization and structure 
determination. Whereas he managed to increase our understanding of Pol I by applying 
lysine-lysine crosslinking coupled to mass spectrometry, solving the Pol I crystal structure 
from the initial crystal form still failed. From Stefan’s work it became clear that a different 
crystal form needed to be obtained for solving the structure. Thus, multiple ideas were raised 
which all had the common goal of obtaining a novel crystal form: (1) Purification of Pol I 
from a different organism could lead to an altered crystallization behaviour. Pol II had been 
recently endogenously purified from Schizosaccaromyces pombe and its structure solved in a 
novel crystal form by the Kornberg lab71. After a proof of principle by this work, a 
comparable approach was intended for S. pombe Pol I. (2) The deletion of Pol I subunits or 
addition of transcription factors and/or nucleic acid scaffolds in either organism may also 
drive an alternative crystallization and hence yield a different crystal form. In line with this, 
proteolytic digest was intended in order to obtain a minimal Pol I. (3) Solving the structure 
from the initial crystal form using up-to-date approaches. X-ray detectors, beamline setups 
and data collection strategies had been improved since the first description of Pol I crystals 
and so have programs for processing and molecular replacement. Additionally, a novel, higher 
resolution EM map could in principle be used in order to obtain novel results for molecular 
replacement which might enable us to solve the structure or at least elucidate the backbone 
Pol I architecture from the original crystal form. 
Firstly, the establishment of novel strains with tagged S. pombe Pol I subunits was required, 
since no tagged strains existed. Furthermore, large-scale fermentation and purification 
approaches as well as crystallization protocols needed to be put in place and optimized. For 
the first Pol I purification protocol, a S. cerevisiae strain was used, which originated from a 
cloning strain and harboured a genomic knockout of the stalk subunit A43 as well as a 
plasmid for the expression of an A43 variant containing a 6x histidine tag at its N-terminus. In 
order to circumvent potential issues arising from the tag-location at the exposed stalk, 
expression differences due to plasmid-based A43 expression or proteolytic degradation during 
purification, a novel S. cerevisiae strain containing a genomic 10x histidine tag at the C-
terminus of A190 and a triple protease knock-out was established. 
With the changes in organism, expression and purification, the aim of this study was to 
produce novel Pol I crystals in order to solve the structure. From the structure, deductions for 
transcriptional mechanisms in general and the synthesis of ribosomal RNA in specific as well 
as for the evolutionary relation between different transcriptions systems were intended. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Strains 
Table 2. Strains used in this study 
 
Strain Genotype Source 
E. coli XL-1 Blue 
rec1A; endA1, gyrA96; thi-1; supE44; elA1; 
lac[F'proAB lacI qZDM15 Tn10(Tetr)] 
Stratagene 
E. coli BL21(DE3)RIL B; F-; ompT; hsdS(rB
- mB-); dcm+; Tetr; gal 
λ(DE3); endA; Hte [argU, ileY, leuW, Camr] Stratagene 
S. cerevisiae CB010 MATa pep4::HIS3; prb1::LEU2; prc1::HISG; can1; ade2; trp1; ura3; his3; leu2-3 
Cramer et 
al. 2000 
S. cerevisiae CB010 A190-his/flag 
MATa pep4::HIS3; prb1::LEU2; prc1::HISG; 
can1; ade2; trp1; ura3; his3; leu2-3; A190::A190-
his/flag_G418R 
This study 
S. cerevisiae CB010 ΔA12.2(75-C) A190-his/flag 
MATa pep4::HIS3; prb1::LEU2; prc1::HISG; 
can1; ade2; trp1; ura3; his3; leu2-3; A190::A190-
his/flag_G418R; A12.2::A12.2Δ75-125_ClonatR 
This study 
S. cerevisiae CARA (Rrn3 fused to A43) Δrrn3::his5+; Δrpa43::kanr; pGEN-RRN3-A43 Laferte et al. 2006 
S. cerevisiae DF5 ΔA190 ycPLAC33-A190 ΔA190::hyg; ycPLAC-A190 +/-250bp Jentsch lab 
S. cerevisiae DF5 ΔA190 pRS314-A190 ΔA190::hyg; pRS314-A190 This study 
S. cerevisiae DF5 ΔA190 pRS314-A190 Δ1337-1441 ΔA190::hyg; pRS314-A190 Δ1337-1441 This study 
S. cerevisiae DF5 ΔA190 pRS314-A190 Δ1361-1395 ΔA190::hyg; pRS314-A190 Δ1361-1395 This study 
S. cerevisiae DF5 ΔA190 pRS314-A190 D1388R ΔA190::hyg; pRS314-A190 D1388R This study 
S. cerevisiae DF5 ΔA190 pRS314-A190 R1015E ΔA190::hyg; pRS314-A190 R1015E This study 
S. cerevisiae DF5 ΔA190 ycPLAC33-A190 pRS314-
A190Δ981-C 
ΔA190::hyg; ycPLAC33-A190; pRS314-
A190Δ981-C This study 
S. pombe 972h- (WT) Wild type Evolution 
S. pombe 972h- A49-his/flag A49::A49-FLAG/10xHIS-kanMX4 This study 
S. pombe 972h- AC40-his/flag AC40::AC40-FLAG/10xHIS-kanMX4 This study 
S. pombe 972h- A14-his/flag A14::A14-FLAG/10xHIS-kanMX4 This study 
S. pombe T611 ade6-M210; ura4-D18; leu1-32; mating type h- Albert at al. 2011 
S. pombe T611 ΔRpa34 ade6-M210; ura4-D18; leu1-32; rpa34::kan-MX4 Albert at al. 2011 
S. pombe T611 ΔRpa51 ade6-M210; ura4-D18; leu1-32; rpa51::URA4 Albert at al. 2011 
S. pombe T611 ΔRpa51/AC40-his/flag 
ade6-M210; ura4-D18; leu1-32; rpa51::URA4; 
AC40::AC40-FLAG/10xHIS-kanMX4 
This study 
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2.1.2 Oligonucleotides 
 
Table 3. Primers used in this study - part I of V 
 
Primer name Sequence 
 
  
Spo-ac40-f01 CCTAAAGGAGTCATCGAGCTTG 
Spo-ac40-r03 GCATCAATTAAAGGCGTCGC 
Spo-a14-f01 CCACCTGAAGAAATGTTGGAA 
Spo-a14-r03 AATATGCAAACTCAAGTACTG 
Spo-a49-f01 TTACTCAACTGATGTTCTTACC 
Spo-a49-r03 CACCTTTAATCCCGTATTCCC 
Hsa-AID-f01 TACCATGGACAGCCTCTTGATGAAC 
Hsa-AID-f02 TACCATGGGGTGCCACGTGGAATTGCTCT 
Hsa-AID-r01h TAGGATCCTCAGTGATGGTGATGGTGATGAAGTCCCAAAGTACGAAATGCG 
Hsa-AID-r02h TAGGATCCTCAATGGTGATGGTGATGGTGCTCATACAGGGGCAAAAGGAT 
pGEX_mut_Nco_fw CTGGTTCCGCGTGGATCCATGGAATTCCCGGGTCGACTC 
pGEX_mut_Nco_rev GAGTCGACCCGGGAATTCCATGGATCCACGCGGAACCAG 
pGEX_mut_Nde_fw CTGGTTCCGCGTGGATCCCATATGTTCCCGGGTCGACTCGAG 
pGEX_mut_Nde_rev CTCGAGTCGACCCGGGAACATATGGGATCCACGCGGAACCAG 
Spo_Elp1_f_Nde TACATATGAAAAATTTGGTAACACACCTGCATC 
Spo_Elp1_N600_6h_r_Not TAGCGGCCGCTTAGTGATGGTGATGGTGATGTCTTTCGGTGCAGAAAAACGATAAGAC 
Spo_Elp1_N662_6h_r_Not TAGCGGCCGCTTAGTGATGGTGATGGTGATGAGGCATTTGTAAAACCACTGCC 
Spo_Elp1_delN632_f_Nde TACATATGCGACACGATGAGCGATGCCGC 
Spo_Elp1_r_8h_Not TAGCGGCCGCTAGTGATGGTGATGGTGATGGTGATGTATTAAAATACTCAATTTTTCAAAAGG 
Spo_Elp1_N1218_6h_r_Not TAGCGGCCGCTAGTGATGGTGATGGTGATGGGGAATAACTTTCTCACCAATAGTAC 
Spo_tag_control_r GTTGGAATTTAATCGCGGCCTCG 
Spo_A14_tag_control CTGGAAGTGAGAGTGTTCTATCCC 
Spo_A49_tag_control CCGGTATTGGTAGCGTCCAAG 
Spo_AC40_tag_control CCTACCGCTTATTGCCTACTATAC 
Spo_Elp1_M1 TCTGGATCCGTTTTAGCAACAATTAAG 
Spo_Elp1_M2 TTTAAAGCTTTAATATACGTACGTACTCCG 
Elp1_Nde_f2 GACATCCATATGAAAAATTTGGTAACACACCTGC 
Elp1_BamH_rev GTTGCTAAAACGGATCCAGATGG 
Elp1_Not_rev AGCCTGCGGCCGCTATTAAAATACTCAATTTTTCAAAAGG 
Elp1_fw_HR AGGAGATATACCATGAAAAATTTGGTAACACACCTGCATC 
Elp1_fw_HR_2 AGGAGATATACCATGGTAACACACCTGCATCATG 
Elp1_rev_HR GTGATGGTGATGTTTTATTAAAATACTCAATTTTTCAAAAGG 
CDC48_Nde_fw ATCACATATGAACGCACCATCCACCATG 
CDC48_Not_rev TAATTGGATCCTGCATACAAATCATCAGCACCATC 
Spo_RRN3_xho_r TGCTCTCGAGAAAGGGAGATTCACCCAACATTACGG 
Spo_Elp1_tap_fw CCACAAGCACCGGTTGTTCCAAACGTTAAACCTTTTGAAAAATTGAGTATTTTAATATCCATGGAAAAGAGAAG 
Spo_Elp1_tap_rev GTAAATCTATATGTAAATGAAAAAATTTCCCCATTTATCCAAAACCAATCCTAACCTACGACTCACTATAGGG 
Spo_Elp1_tap_control GGAGGTTGATCGCTCGTGTTG 
Spo_Elp1_tap_control2 TTCATCGTGTTGCGCAAGAGCCG 
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Table 4. Primers used in this study - part II of V 
 
Primer name Sequence 
  
Sce_A190_10his_fw 
GGGTAAATTGAACAATGTTGGTACGGGTTCATTTGATGTGTTAGCAAAGGTTCCAAATGCGGCTGAT 
TACAAAGATGACGATGACAAGCATC 
Sce_A190_10his_rev 
CTTCTGACCTTCTCCTTCAAATAAACTAATATTAAATCGTAATAATTATGGGACCTTTTGCCTGCTT 
GCATAGGCCACTAGTGGATCTG 
Sce_A190_tag_control GAGCGTGAACAATTGGACAGTCC 
Elp1_seq_1 GCAACAATTAAGTCAGATAGTTCCG 
Elp1_seq_2 GTCCTTGAAACTTTTGGCTTCCG 
Elp1_seq_3 CAGTGATACATCCAAGTCACAGTC 
Spo_Elp1_tap_f2 CCACAAGCACCGGTTGTTCCAAACGTTAAACCTTTTGAAAAATTGAGTATTTTAATACAGCTGAAGCTTCGTACGCTG 
Spo_Elp1_tap_r2 CAGATCCACTAGTGGCCTATGCGGTTAGGATTGGTTTTGGATAAATGGGGAAATTTTTTCATTTACATATAGATTTAC 
GST_Nco_fw TAATCCATGGGCAGCTCCCCTATACTAGGTTATTGG 
GST_Nde_rev TATATACATATGCGATCCACGCGGAACCAGATCCG 
Spo_Elp1_tap_r3 GTAAATCTATATGTAAATGAAAAAATTTCCCCATTTATCCAAAACCAATCCTAACCGCATAGGCCACTAGTGGATCTG 
elp2-nhe-fw CGCGCGGCAGCCATATGGGCTTTCAGTATGAGGCTTTAC 
elp2-nhe-rev GTCCACCAGTCATGCTAGTTATCCCAACGTAACGTTC 
elp3-nhe-fw CGCGCGGCAGCCATATGGGCTCGACTTCCAGTTTGGCC 
elp3-nhe-rev GTCCACCAGTCATGCTAGCTAAAGCCATTTAGACATG 
elp4-nhe-fw CGCGCGGCAGCCATATGGGCTCGTTCAAAAGGAAAGCAGC 
elp4-nhe-rev GTCCACCAGTCATGCTAGCTAAAAATCCAAAGATTTAACAG 
elp5-nhe-fw CGCGCGGCAGCCATATGGGCTCGAAATTCCTTTTGAACCG 
elp5-nhe-rev GTCCACCAGTCATGCTAGTTAAATTAGTAAATCTTCATCAGC 
elp6-nhe-fw CGCGCGGCAGCCATATGGGCTCTTCTTTACACGAGCATTTACG 
elp6-nhe-rev GTCCACCAGTCATGCTAGTTAGAGTTGCAGCGTCACC 
SpE1-nhe-fw CGCGCGGCAGCCATATGGGCAAAAATTTGGTAACACACCTGC 
SpE1-delN208-fw CGCGCGGCAGCCATATGGGCGGCAAAACTTATATTTGCTGG 
SpE1-delN421-fw CGCGCGGCAGCCATATGGGCGTACAAATGACTTCGATAAACG 
SpE1-delN668-fw CGCGCGGCAGCCATATGGGCATTTACCCTAGAATTATGGTTC 
SpE1-delN762-fw CGCGCGGCAGCCATATGGGCATTGACAATAAAGTTAATTTATTG 
SpE1-nhe-rev GTCCACCAGTCATGCTAGCTATATTAAAATACTCAATTTTTCAAAAGG 
SpE1-N1153-rev GTCCACCAGTCATGCTAGCTATCCTCTCGCGCGTTTTCTCTC 
SpE1-N1092-rev GTCCACCAGTCATGCTAGCTAATCTTCTTTTTTCTTCTCTC 
SpE1-N1044-rev GTCCACCAGTCATGCTAGCTAACCGGTGGCGCGAGCAATCCG 
SpE1-N737-rev GTCCACCAGTCATGCTAGCTATAAAGAAGTGAGAAACAAGTC 
SpE1-N661-rev GTCCACCAGTCATGCTAGCTACATTTGTAAAACCACTGCC 
SpE1-N617-rev GTCCACCAGTCATGCTAGCTAAACCAAGTGTACAAATTTAAG 
SpE1-N400-rev GTCCACCAGTCATGCTAGCTATGTGACCAACAGCGAAGAGC 
SpE1-19-rev1 CAATAAATTAACTTTATTGTCAATAACCAAGTGTACAAATTTAAG 
SpE1-19-fw2 CTTAAATTTGTACACTTGGTTATTGACAATAAAGTTAATTTATTG 
CtE1-nhe-fw CGCGCGGCAGCCATATGGGCCGTAACCTGCGCAACATCAG 
CtE1-nhe-rev GTCCACCAGTCATGCTAGTCACACCTTGCCCTCCTTCC 
SpE1-not-r-no-tag TAGCGGCCGCTATATTAAAATACTCAATTTTTCAAAAGG 
CtE1-seq-1 CGAGCTGGATAGTGTGAGTGAGC 
CtE1-seq-2 GCCATGATTTCTCCGCCGTCGAAG 
CtE1-seq-3 GATCAATACCATCTGCGATGC 
Hp_A190_fw GGACGTCGACGCGGCCAAG 
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Table 5. Primers used in this study - part III of V 
 
Primer name Sequence 
  
Hp_A190_rev ACGCATGAAACCGTTCGGCCG 
Hp_A190_c1fw CCGAGTCCGACGACGAAGACG 
Hp_A190_c1r GAACACTGCCAGCGCATCAAC 
Hp_A190_c2fw GTTGATGCGCTGGCAGTGTTC 
Hp_A190_c2r AAGGCTTGAAGTTAGACACAAC 
Spo-elp3-f-sac AAGAGCTCAATAATTTTGTTTAACTTTAAGAAGGAGATATAATGTCGACTTCCAGTTTGGCC 
Spo-elp3-r-xho ATCTCGAGCTAAAGCCATTTAGACATG 
Spo-elp2-f-nde AACATATGTTTCAGTATGAGGCTTTAC 
Spo-elp2-r-sac TAGAGCTCTTATCCCAACGTAACGTTC 
scrrn6-f-e AGGAGATATACCATGAGTGAGGGACAAATTCCAAG 
scrrn6-r-e GTGATGGTGATGTTTTTATCCAAACCCCCGGATCC 
scrrn7-f-bk AAGTTCTGTTTCAGGGCCCGATGTCTACTTTCATAAGAGGTCCC 
scrrn7-r-bk ATGGTCTAGAAAGCTTCAATTCATCCTATGCAGACAGGC 
sc7n210-r-b ATGGTCTAGAAAGCTTCAATAATTTGGCAGCTGGATCCTCC 
scrrn11-f-nco AACCATGGGUTTTGAAGTCCCTATAACTTTAAC 
scrrn11-r-xho AACTCGAGTCACTCACTTGAGTCTTCATCAC 
scrrn6-fw-k AAGTTCTGTTTCAGGGCCCGATGAGTGAGGGACAAATTCCAAG 
scrrn6-rev-k ATGGTCTAGAAAGCTTTATCCAAACCCCCGGATCC 
scrrn11-f-k AAGTTCTGTTTCAGGGCCCGATGTTTGAAGTCCCTATAACTTTAAC 
scrrn11-r-k ATGGTCTAGAAAGCTTCACTCACTTGAGTCTTCATCAC 
sc7-rbs-r AATAATTTTGTTTAACTTTAAGAAGGAGATATACAGTCAATTCATCCTATGCAGACAGGC 
sc6-rbs-f AATAATTTTGTTTAACTTTAAGAAGGAGATATACAGATGAGTGAGGGACAAATTCCAAGC 
sc6-r TTATCCAAACCCCCGGATCC 
sc6-rbs-r CTGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTTATCCAAACCCCCGGATCC 
sc11-rbs-f AATAATTTTGTTTAACTTTAAGAAGGAGATATACAGATGTTTGAAGTCCCTATAACTTTAAC 
sprrn6-f-e AGGAGATATACCATGTCAACATGGCCTATTGATGC 
sprrn6-r-e GTGATGGTGATGTTTTTAAAATCCGCTTCTTTTCTTTTTC 
sprrn7-f-bk AAGTTCTGTTTCAGGGCCCGATGGAAGGCAATTGGTTTGAAGG 
sprrn7-r-bk ATGGTCTAGAAAGCTTTAATCTTGATTGTGTATACCGG 
sp7n232-r-b ATGGTCTAGAAAGCTTCAGTTTTTTTGAAGCCTTTTAAATATTTTTAGAGG 
sprrn11-f-nco AACCATGGGATTCTCTCCTTGTACCGTTAAAG 
sprrn11-r-xho AACTCGAGCTACAATTCGACGTCAATTCCTG 
sp11dn32-f-bam AAGGATCCGTCAAGAAGGTATAAAACAAGAC 
sprrn6-f-k AAGTTCTGTTTCAGGGCCCGATGTCAACATGGCCTATTGATGC 
sprrn6-r-k ATGGTCTAGAAAGCTTTAAAATCCGCTTCTTTTCTTTTTC 
sprrn11-f-k AAGTTCTGTTTCAGGGCCCGATGTTCTCTCCTTGTACCGTTAAAG 
sprrn11-r-k ATGGTCTAGAAAGCTCTACAATTCGACGTCAATTCCTG 
sp7-rbs-r CTGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTTAATCTTGATTGTGTATACCGG 
sp6-rbs-f AATAATTTTGTTTAACTTTAAGAAGGAGATATACAGATGTCAACATGGCCTATTGATGC 
sp6-r TTAAAATCCGCTTCTTTTCTTTTTC 
sp6-rbs-r CTGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTTAAAATCCGCTTCTTTTCTTTTTC 
sp11-rbs-f AATAATTTTGTTTAACTTTAAGAAGGAGATATACAGATGTTCTCTCCTTGTACCGTTAAAG 
scrrn6-dn182-fw-e AGGAGATATACCATGGGCAGCCTGGACTCTCAATATATTCAGAC 
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Table 6. Primers used in this study - part IV of V 
 
Primer name Sequence 
  
scrrn6-n557-rev-e GTGATGGTGATGTTTTTGAGTGTTTGATAAAGCATAG 
scCF-seq-1 GGGAAAGAACGGACGAACG 
scCF-seq-2 TTAGGCTCGCAATTGGGTG 
scCF-seq-3 GGTGGTAGATTTTGCATTC 
scCF-seq-4 GATTCACAACCGCGTAATTC 
spCF-seq-1 CTTAGAAATCTTCATACCTGC 
spCF-seq-2 CTAGTGTAAGTTTGGATTATGG 
spCF-seq-3 CATCTGGCAATTCTTAGATG 
sc7dn320-f-b AAGTTCTGTTTCAGGGCCCGGATAGAGACCGACAATACCC 
sp7dn343-f-b AAGTTCTGTTTCAGGGCCCGAATGTATGTTATGGGTTTGATG 
pOPINK-sequ TTTGGTGGTGGCGACCATCC 
sc190hisCNfw1 
AAGGTTCCAAATGCGGCTCTGGTGCCGCGCGGCAGCCATCACCATCACCATCACCATCACCAT 
CACTGACCTTATGTATCATACACATACG 
sc190TAGfw2 
CGCTAGAATTGTGGTGGGTAAATTGAACAATGTTGGTACGGGTTCATTTGATGTGTTAGCAAA 
GGTTCCAAATGCGGCT 
sc190cnTAGrev 
CTTCTGACCTTCTCCTTCAAATAAACTAATATTAAATCGTAATAATTATGGGACCTTTTGCCT 
GCTTTTAGGGGCAGGGCATGCTCATGTAG 
sc190bioKANfw1 
AAGGTTCCAAATGCGGCTAGCAACAGCGGCCTGAACGATATTTTTGAAGCGCAGAAAATTGAA 
TGGCATGATTACAAAGATGACGATGAC 
sc6dN197-e-fw AGGAGATATACCATGGACGGAACCGAAATCATAGC 
sc6dN576-e-fw AGGAGATATACCATGCTTTTCAATAACGCTGATGAAC 
sc6N763-e-re GTGATGGTGATGTTTGCTGCCGCGCGGCACCAGTGATCGTGAAATTTCGTTTTG 
sc6-e-re-tag GTGATGGTGATGTTTGCTGCCGCGCGGCACCAGTCCAAACCCCCGGATCC 
sp6-e-re-tag GTGATGGTGATGTTTGCTGCCGCGCGGCACCAGAAATCCGCTTCTTTTCTTTTTC 
sc7dN96-b-fw AAGTTCTGTTTCAGGGCCCGGGTCATGAGGCCAAATTAC 
sc7N319-b-re ATGGTCTAGAAAGCTTCAAGAAAGCATCCAATTTATTGTG 
sc7N416-b-re ATGGTCTAGAAAGCTTCAAATCTTGTACAGTTTCCTTCTAG 
sc11dN92-f-nco AACCATGGGAAGCGAAACAGACTCTCAAG 
sc11N322-r-xho AACTCGAGTCATTTTTGGCAATTAATTAAAGAAGACC 
scpol1_prom_fw GTTAAGGCAGAGCGACAGAG 
scpol1_prom_re GTCTTCAACTGCTTTCGCAT 
scRPA12_n75_fw 
AAGAAATCCGTGGTTAAAACTTCTTTGAAGAAGAACGAAGATTACAAAGATGACGATGACAAGTGACCTTAT 
GTATCATACACATACG 
scRPA12_n75_re 
AAAGCGGGGATGATATTAATGTACAAATTGTAATATGTGCGAACACAACCCAATTAGGGGCAGGGCATGCTC 
ATGTAG 
sc_dRPA12c_c_f CTTGGACTGTGGTGATCTCCTG 
sc_dRPA12c_c_r TCGGTGGTGAAGGACCCATCC 
scRPA12_n75_f2 CGTCACCACGACGGCAGACGATGCGTTTCCATCTTCTCTTAGAGCCAAGAAATCCGTGGTTAAAAC 
A190_dEXP_1_f AAATCAAAAAACAAAAGAGAACTACAGGAGTTGACATGAATGAACAAATTAATAAGAG 
A190_dEXP_1_r CTCTTATTAATTTGTTCATTCATGTCAACTCCTGTAGTTCTCTTTTGTTTTTTGATTT 
A190_dEXP_2_f AGATGTTGCAAATAGTTCTTCGAGAGAAGCTGAAAAGTCTTCTG 
A190_dEXP_2_r CAGAAGACTTTTCAGCTTCTCTCGAAGAACTATTTGCAACATCT 
A190_K1377A_f TAATGATGAAGAACAAAGTCATAAGGCAACTAAACAAGCGGTTTCGTATGAC 
A190_K1377A_r GTCATACGAAACCGCTTGTTTAGTTGCCTTATGACTTTGTTCTTCATCATTA 
A190_Y1384A_f AAACTAAACAAGCGGTTTCGGCTGACGAGCCAGATGAAGATG 
A190_Y1384A_r CATCTTCATCTGGCTCGTCAGCCGAAACCGCTTGTTTAGTTT 
A190_D1388R_f GCGGTTTCGTATGACGAGCCACGTGAAGATGAAATTGAAAC 
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Table 7. Primers used in this study - part V of V 
 
Primer name Sequence 
  
A190_D1388R_r GTTTCAATTTCATCTTCACGTGGCTCGTCATACGAAACCGC 
A190_KYD_AAR_f GAACAAAGTCATAAGGCAACTAAACAAGCGGTTTCGGCTGACGAGCCACGTGAAGATG 
A190_KYD_AAR_r CATCTTCACGTGGCTCGTCAGCCGAAACCGCTTGTTTAGTTGCCTTATGACTTTGTTC 
A190_R1015E_f GAAGGTTTAATTGATACGGCCGTTAAAACATCTGAGTCCGGTTATTTGCAACGT 
A190_R1015E_r ACGTTGCAAATAACCGGACTCAGATGTTTTAACGGCCGTATCAATTAAACCTTC 
A190_1380-91A_f GTCATAAGAAAACTAAAGCTGCAGCCGCGGCTGCCGCAGCTGCGGCCGCAGCTATTGAAACTATGAGAGAAG 
A190_1380-91A_r CTTCTCTCATAGTTTCAATAGCTGCGGCCGCAGCTGCGGCAGCCGCGGCTGCAGCTTTAGTTTTCTTATGAC 
A190_c1_r GCTGATAGATTTCTAATCTC 
A190_c2_f ATGGATATTTCTAAACCGG 
A190_c3_f GAAGCATCTGCAAATGACG 
A190_c4_f ATTGACACCATCTTCAAACG 
A190_c5_f CATCTTGAAGACGTCTGTTG 
A190_c6_f GTTTTAGCTAAGTATAATCC 
A190_c7_f TGAGAGAAGCTGAAAAGTC 
A190_c8_f GGTTCATTTGATGTGTTAGC 
A190_insert_f GATGCCATGGCTGGTGGTTATG 
A190_insert_r AATTGGAGCTCCACCGCGG 
polyA_ins_1_r AGCTGCGGCCGCAGCTGCGGCAGCCGCGGCTGCAGCTTTAGTTTTCTTATGACTTTG 
polyA_ins_2_f GCTGCAGCCGCGGCTGCCGCAGCTGCGGCCGCAGCTATTGAAACTATGAGAGAAGC 
KYD_AAR_ins_1_r CGAAACCGCTTGTTTAGTTGCCTTATGACTTTGTTC 
KYD_AAR_ins_2_f ACTAAACAAGCGGTTTCGGCTGACGAGCCACGTGAAGATGAAATTG 
 
2.1.3 Media 
 
Table 8. Media and additives used in this study 
 
Name Description 
Lysogeny broth (LB) 1% (w/v) Tryptone , 0.5 % (w/v) Yeast extract, 8.6 mM NaCl  
ZY 1% (w/v) Tryptone , 0.5 % (w/v) Yeast extract 
20x NPS 170 mM Potassium dihydrogen phosphate, 720 mM Dipotassium hydrogen phosphate 
LB plates 1% (w/v) Tryptone , 0.5 % (w/v) Yeast extract, 8.6 mM NaCl, 1.5 % (w/v) agar, 1x Antibiotic  
X-Gal plates 
1% (w/v) Tryptone, 0.5 % (w/v) Yeast extract, 8.6 mM NaCl, 
1.5 % (w/v) agar, 1x Antibiotic, 0.02% X-Gal dissolved in N,N-
Dimethylformamide (DMF)  
YPD 2 % (w/v) Peptone, 2 % (w/v) Glucose, 1 % Yeast extract 
YPD plates 2 % (w/v) Peptone, 2 % (w/v) Glucose, 1 % Yeast extract, 2 % (w/v) Agar 
Autoinduction “5052” 25 % (v/v) Glycerol, 2.5 % (w/v) Glucose, 10 % (w/v)α-Lactose 
Ampicillin 100 µg/ml final concentration 
Kanamycin 30 µg/ml final concentration 
Chloramphenicol 30 µg/ml final concentration 
Tertacyclin 12.5 µg/ml final concentration 
Streptamycin 50 µg/ml final concentration 
Geneticin 200 µg/ml final concentration 
IPTG 0.1 mM - 1.0 mM final concentration 
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2.1.4 Plasmids 
Table 9. Plasmids used in this study - part I of III 
 
No.  Plasmid Resistance Organism Insert Comment 
1 pET24d Kan       
2 pET24a Amp       
3 pET24d Kan H. sapiens AID Full length 
4 pANY Amp S.pombe A14-FLAG-10xHIS Template for genomic insertion 
5 pANY Amp S.pombe A49-FLAG-10xHIS Template for genomic insertion 
6 pANY Amp S.pombe AC40-FLAG-10xHIS Template for genomic insertion 
7 pET24d Kan H. sapiens AID Construct 2 
8 pET24d Kan H. sapiens AID Construct 4 
9 pGEX-4T-1 Amp hybrid   N-term GST-tag 
10 pGEX-4T-1-CE Amp hybrid   NcoI site inserted to “9” 
11 pET24a Kan S. pombe Elp1.4   
12 pGEX Amp H. sapiens AID Full length 
13 pGEX Amp H. sapiens AID Construct 2 
14 pGEX Amp H. sapiens AID Construct 4 
15 pET21a Amp       
16 pET21d Amp       
17 pET21a Amp S. pombe RPA21/ker1 A14/43 homologue; S. Geiger 
18 pOPINE Amp       
19 pBS1539 Amp     from M. Seizl 
20 pOPINE Amp S. pombe Elp1 Full length 
21 pET28b Kan       
22 pET28b Kan S. pombe Elp1-N600   
23 pET28b Kan S. pombe Elp1-N662   
24 pET28b Kan S. pombe Elp1 Full length 
25 pYM13 Amp       
26 pET21a Amp S. pombe Rrn3 Full length 
27 GFP-Amp Amp hybrid GFP from H. Feldmann 
28 pET28b Kan S. pombe Elp3 Full length 
29 pET28b Kan S. pombe Elp4 Full length 
30 pET28b Kan S. pombe Elp6 Full length 
31 pET28b Kan S. pombe Elp1.2   
32 pET28b Kan S. pombe Elp1.7   
33 pET28b Kan S. pombe Elp1.12   
34 pET28b Kan S. pombe Elp1.13   
35 pET28b Kan S. pombe Elp1.16   
36 pET28b Kan S. pombe Elp1.8   
37 pET28b Kan S. pombe Elp1.9   
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Table 10. Plasmids used in this study - part II of III 
 
No.  Plasmid Resistance Organism Insert Comment 
      
38 pET28b Kan S. pombe Elp1.15   
39 pET28b Kan S. pombe Elp1.17   
40 pET28b Kan S. pombe Elp2 Full length 
41 pET28b Kan S. pombe Elp5 Full length 
42 pET28b Kan S. pombe Elp1.6   
43 pET28b Kan S. pombe Elp1.18   
44 pET28b Kan S. pombe Elp1.5   
45 pET28b Kan S. pombe Elp1.21   
46 pET28b Kan S. pombe Elp1.1   
47 pET28b Kan S. pombe Elp1.3   
48 pET28b Kan S. pombe Elp1.10   
49 pET28b Kan S. pombe Elp1.11   
50 pET28b Kan S. pombe Elp1.14   
51 pET28b Kan S. pombe Elp1.4   
52 pANY Amp H. polymorpha A190-FLAG-10xHIS Template for genomic insertion 
53 pOPINB Kan       
54 pOPINK Kan       
55 pOPINE Amp       
56 pCDF-Duet Strep       
57 pET-TBP Amp S. cerevisiae TBP core from S. Sainsbury 
58 pET28b Kan S. cerevisiae A49/A34.5 both full length; from S. Geiger 
59 pET28b Kan S. cerevisiae Rrn3 Full length; from C. Blattner 
60 pET21b Amp S. cerevisiae A14/A43 both full length; from C. Blattner 
61 pOPINE Amp S. cerevisiae Rrn6 No tag 
62 pOPINB Kan S. cerevisiae Rrn7 N-term 6xhis 
63 pOPINB Kan S. cerevisiae Rrn7-N210 N-term 6xhis 
64 pOPINB Kan S. cerevisiae Rrn6/7/11 N-term 6xhis on Rrn7 / ongoing 
65 pCDFDuet Strep S. cerevisiae Rrn11 No tag 
66 pOPINK Kan S. cerevisiae Rrn6 N-term GST-tag 
67 pOPINK  Kan S. cerevisiae Rrn7 N-term GST-tag 
68 pOPINK Kan S. cerevisiae Rrn11 N-term GST-tag 
69 pOPINE Amp S. pombe Rrn6 No tag 
70 pOPINB Kan S. pombe Rrn7 N-term 6xhis 
71 pOPINB Kan S. pombe Rrn7-N232 N-term 6xhis 
72 pOPINB Kan S. pombe Rrn6/7/11 N-term 6xhis on Rrn7 / ongoing 
73 pCDFDuet Strep S. pombe Rrn11 No tag 
74 pCDFDuet Strep S. pombe Rrn11ΔN32 N-term 6xhis 
75 pOPINK Kan S. pombe Rrn6 N-term GST-tag 
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Table 11. Plasmids used in this study - part III of III 
 
No.  Plasmid Resistance Organism Insert Comment 
      
76 pOPINK Kan S. pombe Rrn7 N-term GST-tag 
77 pOPINK Kan S. pombe Rrn11 N-term GST-tag 
78 pOPINE Amp S. cerevisiae Rrn6 182-557 C-term 6xhis 
79 pOPINK Kan S. cerevisiae Rrn7-N210 N-term GST-tag 
80 pOPINK Kan S. pombe Rrn7-N232 N-term GST-tag 
81 pF6A-NT2 Amp hybrid Clonat resistance Template for genomic insertion 
82 pOPINA Kan      
83 pRS314 Amp/Trp S. cerevisiae A190 +/- ca. 250bp Wittekin 1988 
84 pET28 Kan S. cerevisiae Rrn7 from S. Jennebach 
85 pET21 Amp S. cerevisiae Rrn7 from S. Jennebach 
86 pET28 Kan S. cerevisiae Rrn6 and Rrn11 from C. Blattner 
87 pET21 Amp S. cerevisiae Rrn6 and Rrn11 from C. Blattner 
88 YCplac33 Amp/Ura S. cerevisiae A190 +/- 250bp from I. Heckmann (Jentsch) 
89 YCplac111 Amp/Leu S. cerevisiae A190 +/- 250bp from I. Heckmann (Jentsch) 
90 pRS314 Amp S. cerevisiae A190 Δexpander1_1 originates from 83 
91 pRS314 Amp S. cerevisiae A190 Δexpander1_2 originates from 83 
92 pRS314 Amp S. cerevisiae A190 Δexpander1_3 originates from 83 
93 pRS314 Amp S. cerevisiae A190 Δexpander2_1 originates from 83 
94 pRS314 Amp S. cerevisiae A190 D1388R_1 originates from 83 
95 pRS314 Amp S. cerevisiae A190 R1015E_2 originates from 83 
96 pRS314 Amp S. cerevisiae A190 Δ981-C originates from 83 
97 pOPINE Amp S. cerevisiae Rrn6 C-term 6xHis 
98 pOPINE Amp S. cerevisiae Rrn6 197-763 C-term 6xHis 
99 pOPINE Amp S. cerevisiae Rrn6 577-763 C-term 6xHis 
100 pOPINB Kan S. cerevisiae Rrn7 97-319 N-term 6xHis 
101 pOPINB Kan S. cerevisiae Rrn7 97-416 N-term 6xHis 
102 pCDF Strep S. cerevisiae Rrn11 92-322 No tag 
103 pETDuet Amp S. cerevisiae Rrn7-Rrn11-Rrn6 From B. Knutson & S. Hahn 
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2.1.5 Buffers for the purification of RNA polymerase I 
Table 12. Buffers for Pol I purification 
 
Buffer Component Concentration 
Buffer A HEPES pH 7.8 
MgCl2 
Glycerol 
DTT 
PMSF 
Benzamidine 
Leupeptin 
Pepstatin 
150 mM 
60 mM 
20 % v/v 
5 mM 
1 mM 
1 mM 
60 µM 
200 µM 
Buffer B Potassium acetate 
HEPES pH 7.8 
MgCl2 
Glycerol 
PMSF 
Benzamidine 
β-mercapto-ethanol 
50 mM 
20 mM 
1 mM 
10 % v/v 
1 mM 
1 mM 
10 mM 
Buffer C Potassium acetate 
HEPES pH 7.8 
MgCl2 
Imidazol 
Glycerol 
PMSF 
Benzamidine 
β-mercapto-ethanol 
1.5 M 
20 mM 
1 mM 
10 mM 
10 % v/v 
1 mM 
1 mM 
10 mM 
Buffer D Potassium acetate 
HEPES pH 7.8 
MgCl2 
Imidazol 
Glycerol 
β-mercapto-ethanol 
300 mM 
20 mM 
1 mM 
25 mM 
10 % v/v 
10 mM 
Buffer E Potassium acetate 
HEPES pH 7.8 
MgCl2 
Imidazol 
Glycerol 
β-mercapto-ethanol 
300 mM 
20 mM 
1 mM 
200 mM 
10 % v/v 
10 mM 
Buffer F HEPES pH 7.8 
MgCl2 
Glycerol 
DTT 
20 mM 
1 mM 
10 % v/v 
5 mM 
Buffer G Ammonium sulfate 
HEPES pH 7.8 
MgCl2 
ZnCl2 
DTT 
60 mM 
5 mM 
1 mM 
10 µM 
5 mM 
 
 
Additional buffers are described within the methods they are used for. 
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2.2 Molecular Biology Methods 
2.2.1 Polymerase Chain reaction 
Relevant genes were amplified by polymerase chain reaction (PCR) from genomic DNA of 
Saccharomyces cerevisiae or cDNA from Schizosaccharomyces pombe. Primers are listed in 
Table 3-7 and were purchased from Thermo Fisher Scientific. Colony-PCR was performed 
with self-made Thermus aquaticus polymerase. The total PCR reaction volume was 50 µl 
using Phusion High-Fidelity PCR Master Mix (general lab production; 2x concentrated). Each 
primer was used at a final concentration of 250 nM. In each case, dNTP concentration was 
0.2 mM. Generally, the following protocol was used for initial trials: 
 
180 s 98 °C  Initial denaturation 
15 s 98 °C Denaturation 
60 s 55 °C                          25x Primer annealing 
120 s 72 °C Elongation 
600 s 72 °C Final elongation 
∞ 8 °C Storage 
 
 
2.2.2 Preparation of competent E. coli cells 
Two different strains of chemically competent bacteria cells were used in this study: E. coli 
XL1-Blue and BL21-CodonPlus(DE3)-RIL (see Table 2). For preparation of chemically 
competent cells, a 400 ml culture was grown to an optical density at 600 nm (OD600) of 0.5, 
chilled on ice and centrifuged (Centrifuge 5810 R with an A-4-81 rotor; Eppendorf) for 
10 min at 4,000 rpm and 4°C. The supernatant was removed and the pellet resuspended in 100 
ml of buffer TFB-I (30 mM Potasium acetate pH 5.8, 50 mM MnCl2, 100 mM RbCl, 10 mM 
CaCl2, 15% (v/v) Glycerol) on ice. Subsequently, cells were centrifuged, the supernatant was 
removed and the pellet resuspended in TFB-II (10 mM MOPS pH 7.0, 75 mM CaCl2, 10 mM 
RbCl, 15% (v/v) Glycerol). Finally, 50 µl portions of cell suspension were aliquoted in 
precooled 1.5 ml tubes on ice, flash frozen in liquid nitrogen and stored at -80 °C. 
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2.2.3 Transformation in E. coli and plasmid purification 
Plasmids were transformed in the two E. coli strains BL21-CodonPlus(DE3)-RIL and XL1-
Blue for protein expression and plasmid amplification, respectively. For transformation, 
chemically competent cells were thawed on ice and 0.5 µl of pure plasmid, 2.5 µl of infusion 
reaction product (Clontech) or 5 µl of plasmid ligation product were added (according to the 
respective task). Cells were mixed and placed on ice for 15 min, followed by heat shock for 
40 s at 42 °C and chilling on ice for 2 min. Subsequently, 0.5 ml LB medium was added and 
cells were shaken for 1 h at 37 °C. Cells were then harvested by centrifugation, resuspended 
in fresh LB and plated on LB agar plates with the respective antibiotics. Colonies were picked 
and used to start 5 ml overnight cultures for cloning. Those cultures were used to perform a 
miniprep (Qiagen Kit), which was carried out as recommended by the manufacturer. 
 
2.2.4 DNA digest and ligation 
Plasmids and amplified DNA were digested dependent on the respective cutting sites and their 
application. For in-fusion cloning, reactions were performed in a total volume of 200 µl with 
5 µg of vector, 1x NEBuffer 4 (NEB), 1x Bovine Serum Albumin (BSA) and 40U of each 
restriction enzyme. For classical cloning, reaction volumes of 50 µl were used. The reactions 
were incubated at 37 °C for 3 h and purified via Agarose gels (Gel extraction, Qiagen) or PCR 
purification (Qiagen).  
For in-fusion cloning, reactions were incubated with commercially available dry-down 
components according to the manufacturer's instructions (Clontech). 
Classical ligation was performed in a total reaction volume of 20 µl with 1 µl T4 ligase (NEB) 
in the supplied buffer with 75 ng of digested vector and 5-10 fold molar excess of insert. 
Reactions were incubated at RT for 1 hour or 16 °C over night and transformed into 
chemically competent E. coli XL1-Blue. 
 
2.2.5 Preparation of competent yeast cells and DNA transformation 
This protocol was used for all S. cerevisiae as well as S. pombe transformations. A 20 ml 
YPD culture was inoculated with a single yeast colony from a YPD plate and grown over 
night at 30°C. On the next day, OD600 was determined and a new 100 ml culture started with 
an OD600 of 0.25. After 5-6 hours, OD600 was at 1.0 and cells were harvested in 250 ml 
conical tubes (2500 rpm, 5 min). The medium was discarded, cells were resuspended in 25 ml 
 
 
36 
 
sterile water by vortexing and centrifuged again. Water was discarded and the cells 
resuspended in 1 ml of sterile 100 mM Li2Ac solution (freshly diluted from 1 M stock). The 
suspension was then transferred into a 1.5 ml reaction tube and centrifuged for 15 sec (table 
top centrifuge, full speed). Supernatant was removed and the pellet resuspended in 400 µl of 
fresh 100 mM Li2Ac. In parallel, 500 µl of salmon sperm DNA (2 mg/ml) were boiled at 
95°C for 5 min and quickly chilled on ice. The cells were then split into 100 µl aliquots, 
pelleted and the supernatant removed. To each pellet, the following transformation mix was 
added in the following order: (1) 240 µl sterile PEG3350 (50% w/v), (2) 36 µl 1 M Li2Ac, (3) 
50 µl salmon sperm DNA (2 mg/ml), and (4) 34 µl PCR product of the insertion construct (or 
2 µl plasmid DNA plus 32 µl water). Tubes were vigorously vortexed for more than 1 min 
and incubated at 30°C for 30 min under shaking. Subsequently, reactions were transferred to a 
42 °C heating block and incubated under shaking for 25 min. Cells were then pelleted (table 
top centrifuge at 8000 rpm for 15 s), the supernatant removed and cells were resuspended in 1 
ml YPD medium. Cells were transferred into 15 ml conical tubes and shaken at 30 °C for 3 h. 
After centrifugation at 2500 rpm for 5 min, the pellet was resuspended in 500 µl sterile water 
and plated on YPD plates with the respective marker in two fractions (one plate with 100 µl 
and one with 400 µl). The plates were incubated at 30 °C for 3-4 days, single colonies picked 
and re-plated on fresh plates. For verification of correct genomic insertion, the respective 
genes were amplified by PCR and sequenced. 
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2.3 Biochemical Methods 
2.3.1 Fermentation of S. cerevisiae 
In order to obtain large amounts of cell mass for Pol I purification from yeast, large scale 
fermentation in 200 l scale was performed essentially as described8 with specific changes. A 
sample from the respectively used S. cerevisiae cryo stock was plated on YPD and grown for 
48 hours at 30°C. Precultures of 50 ml were inoculated from those plates and grown 
overnight. From those, 2 l cultures were started and grown over 8-12 h at 30 °C. Meanwhile, 
YPD medium was prepared, pH was adjusted to 7.0 with NaOH and the medium was 
autoclaved in a 200 l fermenter. The 2 l cultures were inspected via light microscopy, 
combined and transferred into the fermenter to reach a final optical density at 600 nm (OD600) 
of 0.20 – 0.25. Ampicillin and Tetracylin were added (100 µg/µl and 50 µg/µl final 
concentration, respectively) to avoid bacterial contamination. Antifoam reagent was added to 
reduce foaming during the fermentation. Cells were grown at 30 °C, 82 Nl/min (normal litres 
per minute) air influx and 250 rpm stirring for ~10 hours until an OD600 of 1.8 - 2.2 was 
reached. Cells were harvested with a continuous-flow centrifuge, resuspended in freezing 
buffer (Buffer A; 50% slurry) and flash frozen in liquid nitrogen for storage at -80°C. 
 
2.3.2 Fermentation of S. pombe 
The fermentation of S. pombe in large scale was subject to trial-and-error based optimization 
which finally yielded a reproducible protocol: S. pombe cells were plated on YPD from a cryo 
stock and grown at 30°C for 48-72 h. A preculture of 500 ml was started and grown over 
night in YPD at 30°C under shaking. Cells were inspected for contaminations via light 
microscopy and secondary cultures of 2 l each were inoculated at a starting OD600 of 0.3 - 0.5. 
After 10-12 h, cells were inspected and transferred into the 200 l fermenter at a starting OD600 
of 0.30-0.35. YPD medium was prepared in the fermenter, but pH was not adjusted and was at 
~6.0 initially. The medium was autoclaved and Ampicillin and Tetracyline were added to 
final concentrations of 100 µg/µl and 50 µg/µl, respectively. Antifoam reagent was added to 
reduce foaming during the fermentation. The fermenter was operated at 22 Nl/min (normal 
litres per minute) air influx and with 250 rpm stirring at 30°C. After 11-13 h, an OD600 of 6.0 
to 7.5 was reached and cells were harvested with a continuous-flow centrifuge, resuspended in 
freezing buffer (Buffer A; 50% slurry) and flash frozen in liquid nitrogen for storage at -80°C. 
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2.3.3 Pol I purification 
Pol I enzyme used for crystallization was essentially obtained as described8, using a protocol 
that was based on a procedure originally established by the Tschochner laboratory76, but with 
several changes. Pol I was purified from the expression-optimized strain CB010 expressing a 
C-terminal Flag/10×histidine-tagged subunit A190. For purification, 500 g of yeast cells were 
lysed by bead beating in buffer A after the addition of ammonium sulphate to 400 mM from a 
3 M stock at 4 °C. The lysate was cleared by centrifugation (30 min at 10,000 xg) and 
ultracentrifugation (90 min at 30,000 xg) and dialysed overnight against buffer B (50 mM 
potassium acetate, 20 mM HEPES, pH 7.8, 1 mM MgCl2, 10% (v/v) glycerol, 10 mM β-
mercaptoethanol, 1 mM PMSF and 1 mM benzamidine). After centrifugation (60 min at 
18,500 xg) the pellet was re-suspended in buffer C (1.5 M potassium acetate, 20 mM HEPES, 
pH 7.8, 1 mM MgCl2, 10 mM imidazole, 10% (v/v) glycerol, 10 mM β-mercaptoethanol, 
1 mM PMSF and 1 mM benzamidine) and incubated with 8 ml Ni-NTA beads (Qiagen) for 
4 h. Bound protein was washed with five column volumes (CV) buffer C, followed by 5 CV 
buffer D (300 mM potassium acetate, 20 mM HEPES, pH 7.8, 1 mM MgCl2, 25 mM 
imidazole, 10% (v/v) glycerol, 10 mM β-mercaptoethanol) and eluted in 5 CV buffer E 
(buffer D but containing 200 mM imidazole). The eluate was loaded on a 10/100 MonoQ 
anion exchange column (GE Healthcare) and eluted with a gradient from 0.3 to 2.0 M 
potassium acetate in buffer F (20 mM HEPES, pH 7.8, 1 mM MgCl2, 10% (v/v) glycerol and 
5 mM DTT). Eluted Pol I was diluted from 1.1 to 0.2 M potassium acetate, loaded on a 5/50 
MonoS cation exchange column (GE Healthcare) and eluted with a gradient from 0.2 to 1.0 M 
potassium acetate in buffer F including a plateau at 350 mM potassium acetate. Pol I eluted at 
490 mM, was concentrated to 500 µl and applied to a Superose 6 10/300 size exclusion 
column (GE Healthcare) in buffer G (60 mM ammonium sulphate, 5 mM HEPES, pH 7.8, 
1 mM MgCl2, 10 µM ZnCl2, 5 mM DTT). A single peak contained up to 1.8 mg of 
homogenous and pure Pol I. 
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2.3.4 Expression and purification of recombinant proteins 
The protocols for recombinant expression and purification of proteins that were used in this 
work have been previously described. The initiation factor Rrn3 was obtained from S. 
cerevisiae44 and from S. pombe (this study) with the same protocol. Core Factor consisting of 
Rrn6, Rrn7 and Rrn11 was prepared similar to the strategy developed in David Schneiders 
lab26 with several modifications developed together with T. Gubbey during his master 
thesis77. Single domains from Core Factor were designed, expressed and purified during this 
work as well77. The work on elongator complex protein 1 (Elp1) from S. pombe was a part of 
this work and has been partially documented during internships by S. Bussemer78 and S. 
Neyer79. A strategy for the recombinant expression and purification of Elp1 and its 
subdomains has been developed and yielded functional protein in sizable quantities for the 
first78,79. However, results obtained on Elp1 will not be topic of this thesis. Recombinant Pol I 
subunit complexes A14/A43 and A49/A34.5 were expressed and purified as developed by S. 
Geiger8,11. 
 
2.3.5 Protein analysis 
Sodium dodecyl sulphate - polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
with the commercially available NuPAGE system (Invitrogen) using 12% acrylamide gels for 
polymerase samples and 4-12% gels for other proteins. Protein samples were incubated with 
5x SDS-loading dye (25 % Glycerol, 7.5% (w/v) SDS, 250 mM Tris-HCl pH 6.8, 0.5 % 
Bromphenol blue, 12.5% β-Mercatoethanol) to achieve a final concentration of 1x. Gels 
were run in 1x MOPS buffer (Invitrogen) at 150-200 V using a prestained protein marker 
(Invitrogen) as molecular weight standard. Gels were stained with instant blue (Expedeon). At 
low protein concentrations, TCA-precipitation was performed in order to enrich the sample or 
gels were silver stained. 
For silver staining, gels were soaked in 50% ethanol for 20 min and 5% ethanol (also 20 min). 
Gels were then incubated 5 min in 35µM DTT solution and transferred to silver nitrate 
solution (1 mg/ml AgNO3, 1.3 mM formaldehyde) for 10 min. Gels were rinsed twice with 50 
ml Millipore water and subsequently washed twice with 25 ml chilled developing solution (30 
mg/ml Na2CO3, 6.6 mM formaldehyde). Developing was performed for 3-8 min in developing 
solution and stopped with solid citric acid monohydrate. 
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Trichloroacetric acid (TCA) precipitation was performed by adding TCA to a final 
concentration of 10%. Samples were incubated on ice for at least 30 min, centrifuged (table 
top) at full speed for 15 min and the supernatant was removed. The pellet was washed with 1 
ml of acetone (-20°C) and again centrifuged 15 min at full speed. Supernatant was removed 
and the residual acetone evaporated for 10 min at RT or 3 min at 95 °C. The final protein 
pellet was then dissolved in 15 µl water and 5 µl 5x SDS loading dye. If required, pH was 
adjusted by the addition of ammonia vapour in trace amounts. 
Protein concentration was determined by absorption measurement at 280 nm using a 
Nanodrop spectrometer (Thermo Scientific).  
Dynamic light scattering (DLS) was performed and evaluated with a Wyatt instrument at the 
MPI for Biochemistry (Martinsried, Germany) core facility. 
 
2.3.6 Transcription assays 
All elongation and cleavage assays were performed exactly as described8,80. Unspecific 
initiation assays were performed as described81. 
 
2.4 Crystallization and structure solution 
2.4.1 Pol I crystallization and microseeding 
Freshly purified Pol I was subjected to commercial screens and to crystallization conditions 
that had previously produced RNA polymerase crystals from different organisms. MRC-2 
microplates (96-well format; SWISSCI) were set up with 100 nl sitting drops using the 
Phoenix pipetting device (Art Robbins). Initial crystals were obtained in 10% PEG 4000, 
300 mM ammonium acetate, 50 mM HEPES, pH 7.5, and 5 mM TCEP at 20 °C. These 
crystals formed thin plates that poorly diffracted X-rays. 
For microseeding, a complete drop containing Pol I crystals was transferred into a seed bead 
aliquot (Hampton Research) and 60 µl of reservoir solution was added. After vortexing 
(2x 90 s) and sonication (2x 90 s) 50 nl of seed solution was added to each drop of either 200 
nl + 200 nl fresh protein + reservoir solution after they were set up with the Phoenix pipetting 
device (Art Robbins). Optimization and micro-seeding yielded brick-like crystals with a size 
of up to 300 × 60 × 40 µm using as reservoir solution 8% PEG 4000, 300 mM ammonium 
acetate, 50 mM imidazole, pH 7.0, and 5 mM TCEP. After a two-step transfer (30 min each 
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step) to the same buffer containing an additional 20% PEG 400, crystals were harvested, 
flash-frozen and stored in liquid nitrogen. 
2.4.2 Data collection and processing 
Diffraction data were collected at the Swiss Light Source in Villigen, Switzerland, on 
beamlines PX1 and PX2 as well as at the European Synchrotron Radiation Facility in 
Grenoble, France, on beamlines ID23-1 and ID29 using Pilatus 6M detectors. Wavelengths, 
increment, flux and total rotation were adapted to the respective crystal and are given in 
(Table 13 and 14). Data were processed with XDS82 and showed P1 symmetry (Table 13 and 
14). An exemplary XDS script is presented in Appendix 6.2.1. A two-fold non-
crystallographic symmetry (NCS) axis was detected by calculation of a self-rotation function 
using program MOLREP and the CCP4 suite83. Analysis of the Matthews coefficient was 
performed via a web server as well as the program matthews in the CCP4 suite and suggested 
the presence of two molecules per asymmetric unit as well as the self-rotation function. 
2.4.3 Phasing 
Molecular replacement using as search models Pol II58, a Pol I homology model62 or a Pol I 
electron microscopic envelope8 failed. For this, the programs Molrep83 and Phaser84 were 
applied. Soaking with heavy metals as well as cluster derivates was attempted but either 
destroyed the crystal or could not be detected. We could, however, use anomalous diffraction 
from intrinsically bound zinc ions for phasing. After performing a fluorescence scan, three 
data sets were collected from a single crystal at the peak, inflection, and low-energy remote 
wavelengths (Table 14). From the peak data set, the positions of 14 zinc ions (7 in each Pol I 
complex) were determined with SHELX C and D85. The occupancies calculated by SHELX 
were between 100% and 58% for the first 14 sites, followed by a drop to ~25% for additional 
peaks that were not considered. Zinc positions were refined using autoSHARP86 in a 
multiwavelength anomalous diffraction experiment using four wavelengths (Table 13 and 14). 
Two Pol II-based homology models of the Pol I core were fitted to match the experimental 
zinc positions using the program MOLOC. Initial phases at 3.5 Å resolution were obtained 
with autoSHARP86 and yielded a first electron density map. Following solvent flattening with 
SOLOMON86 using the positioned homology models as an initial mask, the program 
PARROT87 performed automated NCS averaging and extended phases to 2.8 Å resolution. 
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2.4.4 Model building and refinement 
An atomic model of Pol I was built with COOT88 starting from the positioned homology 
models. The PHENIX suite84 was used to refine the structure with manually assigned rigid 
body groups considering domain boundaries, and independent TLS parameterization for a 
total of 24 TLS groups. NCS restraints with groups defined according to the rigid bodies and 
individual atomic displacement parameters were applied during refinement. In the later stages 
of refinement, prominent water molecules and two bound sulphate ions were placed and 
validated by visual inspection. The final refinement script and parameterization files are 
displayed in Appendix 6.3. The final model has an Rfree factor of 21.0% at 2.8 Å resolution 
and excellent sterochemistry (Table 13). For visualization, secondary structure was assigned 
with DSSP89 and by inspection. The model has been deposited in the Protein Data Bank 
(PDB) under the accession code 4C2M. 
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3. Results and Discussion 
3.1 Purification of S. cerevisiae Pol I 
In order to optimize purity, homogeneity and yield of Pol I, several parameters in 
fermentation, tag-type and -location as well as purification were probed and fine-tuned (see 
Methods). Finally, the strain CB010 with a C-terminal Flag/10xHistidine tag on the largest 
Pol I subunit A190 was used. The strain carries a triple protease knockout and was used for 
purification of a 10-subunit variant of Pol II, from which its structure was solved in the first 
place57. Cells were grown to an optical density at 600 nm of 2.0 which corresponds to mid 
logarithmic growth phase. In principle, the previously used purification technique was 
maintained8. In brief, cells are broken and debris removed. After precipitation, Pol I is re-
solubilized and Ni-NTA affinity chromatography performed, followed by anion- as well as 
cation-exchange chromatography and a final size exclusion step. Due to the higher number of 
histidines in the affinity tag it was possible to include imidazole in the loading and washing 
buffers for the Ni-NTA affinity chromatography step. Figure 6 displays anion- and cation-
exchange as well as size exclusion (SEC) chromatograms and the corresponding SDS-PAGE 
gels. Purified Pol I was active in DNA-templated RNA extension and in RNA cleavage 
(Figure 7). 
 
3.2 S. cerevisiae Pol I crystallizes in three different forms, of which one is suitable for 
structure determination 
With the Pol I obtained using the adapted fermentation and purification protocol, it was first 
attempted to reproduce the initial Pol I crystals75. Initial crystalline precipitate was obtained in 
the original PEG 6000 condition and could be optimized by micro-seeding (streak seed) to 
yield crystal form A as shown in Figure 8. Crystals of form A diffracted as poorly and 
displayed the same unit cell as previously observed. The best dataset did not exceed 7 Å 
resolution and sustained extreme radiation damage which resulted in a fluctuation of 10 Å in 
length of the longest crystallographic axis during data collection (data not shown). Measures 
to minimize radiation damage such as manual translation or helical wheel data collection did 
not resolve the issue. Optimization of crystals by dehydration and or additive screening as 
well as alternative seeding strategies did not improve diffraction as previously described80. 
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Figure 6. Purification of Pol I. 
a-c The three last steps of Pol I purification are MonoQ anion exchange, MonoS cation exchange and Superose6 
size exclusion chromatography in that sequence (see Methods). All chromatograms are displayed with 
absorption at 280 nm (A280) in blue and absorption at 260 nm (A260) in red. Elution parameters are indicated 
above the respective peaks: Potassium acetate concentration and conductivity for ion exchange and elution 
volume for SEC. d A Coomassie-stained SDS-PAGE of the final SEC peak displays all 14 subunits of Pol I. 
 
 
Figure 7. Purified Pol I is active in elongation and 
cleavage of a preannealed elongation scaffold. 
Purified S. cerevisiae Pol I and Pol II can extend RNA in 
a DNA–RNA scaffold in the presence of nucleoside 
triphosphate substrates (NTPs). In the absence of 
nucleoside triphosphate substrates, Pol I cleaves RNA. 
Transcription assays were performed as described8 using 
the DNA–RNA scaffold shown. After running a 20% 
acrylamide urea gel, RNA was detected by fluorescence. 
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Figure 8. Initial Pol I crystals of form A in the PEG 6000 condition75. 
a Crystals of form A obtained from initial drop setups as described. b Crystals of form A obtained from streak 
seeding of a. c Crystals of form A obtained from streak seeding of b. d and e Crystals of form A as displayed in c 
after manipulation with micro-tools and fishing in cryo-protectant solution, respectively. f Diffraction pattern of 
e: Diffraction is visible to ~7 Å with anisotropic spots to ~4.5 Å. Spots display a “comet-like” appearance and 
decay rapidly upon radiation damage. 
 
An alternative crystal form B was obtained by screening in a PEG 3350 condition (Figure 9). 
While the initial needles only diffracted powder-like, optimization with the additive NDSB-
201 (a non-setergent sulfobetaine) yielded improved rods. Improved rods diffracted X-rays 
but displayed a unit cell of ~575 x 286 x 237 Å³ and angles of 90°, 95° and 90° in the C2 
space group. It was thus concluded that form B is the same crystal form as form A, even 
though it grows in a different condition and is obtained with an additive and not from micro 
seeding. Hence, crystal form B was found not to be suitable for structure determination as 
well. 
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On the hunt for a new Pol I crystal form, all conditions that were previously found to 
crystallize multi-subunit polymerases were screened. In the PEG4000 condition, in which the 
structure of S. pombe Pol II was solved, I obtained a novel Pol I crystal form C of very small 
rods that grew from a single nucleation point and oriented in a star-shape (Figure 10). Initial 
X-ray diffraction from a tiny crystal was to low resolution and highly anisotropic. 
Nevertheless, spots were strong but could hardly be indexed. From the relatively high distance 
of spots on one axis, however, it could be speculated that this crystal form lacks the 
extraordinarily long crystallographic axis that in characteristic for crystal forms A and B. 
Optimization of crystal form C proved challenging, since it turned out to be poorly 
reproducible in larger drops. Therefore, optimization was carried out in screening drops as 
 
Figure 9. Crystal form B in a 
PEG 3350 condition. 
a A new needle-like crystal form 
B was obtained in PEG 3350 
conditions. b Initial crystals of 
form B as displayed in panel a 
diffract X-rays in a powder-like 
fashion to a resolution of ~7 Å. 
c Optimization of crystals from 
panel a with additives yielded a 
more space-filling rod. d 
Diffraction of optimized crystals 
from panel c shows clear spots to 
~6.5 Å. Analysis shows a unit cell 
similar to the one of crystal form 
A. Hence, the same crystals seem 
to form under entirely different 
conditions, both are not suitable 
for structure determination. 
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Figure 10. Crystal form C, 
initial diffraction and 
crystal optimization. 
a and b Initial crystals of the 
novel form C in a PEG4000 
condition (see Methods). c 
Initial diffraction of the 
crystal in panel a. Despite a 
strong anisotropic 
diffraction, spots are clearly 
defined and display a 
relatively large spacing, 
hinting for smaller axes 
compared to crystal from A 
and B. c and d The first 
round of optimization in 
screening drops improved 
the crystals to 3-
dimensional plates. f-h Final 
crystals of form C after 
several rounds of 
optimization. Crystals are 
either plates or bricks. Thick 
plates as shown in panel f 
diffracted to the highest 
resolution. 
 
described (Methods). Whereas additives and drop ratio variations hardly influenced 
crystallization, micro-seeding by using crushed crystals as a third drop component resulted in 
a striking improvement of crystal quality. Crystals of the novel form C now grew to sizes of 
up to 350 µm on the long axis and turned out to actually be plates, not rods (Figure 10e-h). 
3.3 Data collection and processing 
Optimized crystals of form C diffracted X-rays well to a resolution of 2.8Å in the best case. 
Figure 11a displays a diffraction image of the crystal CE188 (panel b). Processing (see 
Methods) revealed a triclinic unit cell with axes of 122.8Å x 139.1Å x 209.6Å and angles of 
108.0°, 95.4° and 93.8°. Completeness and redundancy of the data were high and data from 
different crystals and/or datasets scaled together very well. Matthew coefficient analysis as 
well as a self-rotation function both suggested the presence of two molecules in the 
asymmetric unit (AU). The best datasets from four different crystals were merged in order to 
obtain the best possible results (see Table 13). 
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Figure 11. X-ray diffraction 
of crystal form C. 
a Diffraction image of crystal 
CE188 (shown in b). Clear 
data and well-defined spots to 
a resolution of ~2.8Å are 
visible. c Initial indexing 
shows the triclinic unit cell 
(see text). d Data collection 
statistics for one dataset from 
the crystal CE188. Note the 
low Rmerge in low resolution 
shells and the high 
redundancy as well as 
completeness and intensity of 
the data. 
 
 
3.4 Solving the structure of Pol I 
For phasing, molecular replacement was attempted but did not yield a conclusive solution (see 
Methods). Hence, experimental phasing was performed. In our laboratory, Pol II crystals have 
been phased solely from anomalous diffraction of intrinsically bound zinc atoms beforehand 
(A.C. Cheung, personal communication). Therefore, the same strategy was applied to solve 
crystal form C of Pol I. A fluorescence scan on Pol I crystals failed to detect a signal on the 
zinc absorption edge of the original crystals, but succeeded on the optimized, thick crystals of 
form C. Datasets were collected from a single crystal (CE175) in a multi wavelength 
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anomalous diffraction (MAD) scenario on the peak, inflection and low energy remote 
wavelengths (Table 14). The positions of 14 zinc atoms were determined from the peak 
dataset in a single wavelength anomalous diffraction (SAD) experiment (Methods; Figure 12). 
With a manual fit, two models of the 10-subunit Pol II core could be placed on the initial zinc 
positions. With those positions, a three dimensional fit in the unit cell of crystal form C was 
obtained (Figure 12c). The phase information of the positioned homology models and the 
intrinsic zinc atoms in a four-wavelength MAD scenario (together with the data shown in 
 
Table 13. Diffraction data and refinement statistics. 
 
 Crystal I - IV 
Data collectiona  
Space group P1  
Cell dimensions     
    a, b, c (Å) 122.7, 139.0, 209.6  
    α, β, γ  (°)  108.1, 95.4, 93.8  
Resolution (Å) 40-2.8 (2.87-2.80)b  
Rsym  24.0 (201.8)  
I/σI 9.61 (1.52)  
Completeness (%) 99.9 (99.8)  
Redundancy 13.1 (11.5)  
CC(1/2)c (%) 99.6 (54.1)  
   
Refinement   
Resolution (Å) 40-2.80  
No. of reflections 320,814  
Rwork/ Rfree 16.8/21.0  
No. amino acid residues 8,681  
No. of atoms   
    Protein 68,820  
    Ligand/ion 24  
    Water 214  
B-factors (Å2)   
    Protein 81.1  
    Ligand/ion 130.4  
    Water 53.8  
R.m.s deviations   
    Bond lengths (Å)  0.010  
    Bond angles (º) 1.26  
Ramachandrand    
    Preferred/allowed/disallowed (%) 94.5/4.6/0.9  
aDiffraction data were collected at beamline X10SA of the Swiss Light Source, Switzerland, and ID23-1 as well 
as ID29 of the European Synchrotron Radiation Facility ESRF in Grenoble, France, and processed with XDS82. 
Data were collected at 0.25° or 0.1° increments (180° or 360° in total, respectively) at a wavelength of 1.0 Å. 
Datasets of four crystals were merged. The Rpim values were 0.072 (overall, 40-2.8 Å), 0.026 (40-15.3 Å); 0.659 
(2.85-2.80 Å). 
bNumbers in parenthesis refer to the highest resolution shell. 
cCC1/2 = percentage of correlation between intensities from random half-datasets90. 
dCalculated with MolProbity91. 
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Table 13 as a high energy remote) sufficed to generate an initial map. This map already 
clearly displayed secondary structure features that could be correlated to their Pol II 
counterparts (Figure 12d). The positioned polymerases were subsequently used as masks for 
automatic solvent flattening and phase extension (see Methods). The program PARROT was 
used and yielded an electron density map that was suitable for building the structure of Pol I 
at atomic resolution. All scripts used for structure determination are given in the appendix of 
this work. The structure of both molecules in the AU was built manually and refined at 2.8 Å 
resolution to an Rfree factor of 21.0%. It comprises a Pol I dimer containing 8,681 amino acid 
residues, and lacks only the mobile A49 tWH domain and several surface loops. 
 
Table 14. MAD diffraction data collection statistics. 
 
 Peak Inflection Remote 
Data collectiona    
Wavelength (Å) 1.28288 1.28382 1.29639 
Cell dimensions      
    a, b, c (Å) 122.0, 139.2, 209.1   
    α, β, γ  (°)  108.3, 95.1, 94.2   
Resolution (Å) 40-3.5 (3.59-3.50)b 40-3.5 (3.59-3.50) 40-3.5 (3.59-3.50) 
Rsym  15.1 (54.3) 17.0 (74.1) 21.3 (99.8) 
I/σI 16.54 (6.0) 8.14 (2.0) 6.53 (1.4) 
Completeness (%) 98.0 (97.9) 97.2 (95.5) 97.1 (95.5) 
Redundancy 9.8 (9.9) 5.0 (5.0) 5.0 (4.9) 
CC(1/2)c (%) 99.7 (94.5) 99.0 (67.9) 98.5 (47.3) 
aDiffraction data were collected on a Pilatus 6M detector at beamline X06SA of the Swiss Light Source, 
Villigen, Switzerland and processed with XDS82. Data were collected in 0.1° increments (1080° in total). As a 
high-energy remote dataset, the data given in Table 13 were used. 
bNumbers in parenthesis refer to the highest resolution shell. 
cCC1/2 = percentage of correlation between intensities from random half datasets90. 
 
 
Figure 12. Phasing Pol I with 
intrinsically bound zincs. 
a The occupancy of 14 zinc sites that were 
determined by SHELX in a SAD scenario 
is shown. All sites above 50% were 
considered; <30% sites were discarded as 
noise or bound solvent molecules. b The 
sites from panel a can be related to each 
other by rotation around a two-fold axis. 
This agrees with the presence of two 
molecules in the asymmetric unit. c Two 
Pol II core models positioned according to 
zinc positions (coloured chains) can pack 
in three dimensions in crystal form C. 
d Initial density shows secondary structure 
elements at positions corresponding to 
their Pol II counterparts. Here, the funnel 
helices of Rpb1/A190 are shown. 
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3.5 Pol I structure 
The structure of Pol I in crystal form C reveals the 10-subunit Pol I core and the 
subcomplexes A49/A34.5 and A14/A43 on opposite sides (Figure 13). Compared with the 
largest Pol II subunit Rpb1, subunit A190 contains insertions in its domains clamp, dock, 
cleft, pore and funnel, and lacks parts of the clamp head, foot, jaw and cleft domains (Figure 
13c, Figure 14a and c,  Figure 32 and Figure 35a). The jaw domain contains a long insertion 
that we name ‘expander’. The clamp head contains a helical insertion at the position of the 
archaeal polymerase subunit Rpo1373. Compared to the Pol II subunit Rpb2, subunit A135 
contains a truncated external 1 domain, an extended protrusion, and a clamp insertion (Figure 
13c and Figure 14 b and d, Figure 33 and Figure 35b). 
 
 
Figure 13. Crystal structure of Pol I. 
a Subunit interactions and colour key. The thickness of the connecting lines corresponds to the surface area 
buried in the corresponding interfaces. Subunits A190, A135, AC40, A14, Rpb5, Rpb6, A43, Rpb8, A12.2, 
Rpb10, AC19, Rpb12, A49, A34.5 and the A43 connector from the adjacent Pol I enzyme in the dimer 
correspond to chains A, B, C, D, E, F, G, H, I, J, K, L, M, N and O, respectively, in the PDB coordinate file. b 
Top and side views58 of a ribbon representation of the Pol I structure. The mobile A49 tWH domain11 was 
positioned according to crosslinking information62. c Regions that differ in fold between Pol I (left) and Pol II 
(right). Regions with Pol-I- and Pol-II-specific folds are in green and red, respectively. 
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Figure 14. Structure of the two largest Pol I subunits. 
a Schematic of domains and domain-like regions of the largest subunit A190, based on the Pol II nomenclature58. 
The amino acid residue numbers at the domain boundaries are indicated. Apparent amino acid insertions and 
deletions compared with Rpb1 are marked. b Schematic of domains and domain-like regions of the second 
largest Pol I subunit A135, based on the Pol II nomenclature58 as in a. c Ribbon diagram of A190. The thumbnail 
shows the location of A190 within Pol I. Locations of N and C termini are indicated. Colour-coding as in a. Top 
view as in Figure 13. Labelling of corresponding secondary structure elements is as for Pol II58. New or lacking 
secondary structure elements are labelled. New elements were named according to the preceding Pol II element, 
with lower-case letters added alphabetically for subsequent elements. d Ribbon diagram of A135 as in c. The 
thumbnail shows the location of A135 within Pol I.  
 
A heterodimer of AC40 and AC19 resembles Rpb3/Rpb11 in Pol II, but AC40 contains an 
additional ‘toe’ domain where the archaeal subunit D contains a domain with an iron-sulphur 
cluster3 (Figure 13c and Figure 15). Subunit A12.2 binds with its N-terminal zinc ribbon 
domain (N-ribbon) where the homologous Rpb9 domain binds Pol II58, but its C-ribbon binds 
in the pore like transcription elongation factor IIS (TFIIS)92 (Figure 16), consistent with 
crosslinking62. A detailed structural alignment of the two large subunits A190 and A135 as 
well as of AC40 and AC19 with their respective Pol II counterparts is displayed in Appendix 
6.6 (Figure 34). 
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Figure 15. Structure of the subassembly AC40/AC19/Rpb10/Rpb12. 
a Schematic of domain structures. AC40 and AC19 were aligned with homologous Pol II subunits Rpb3 and 
Rpb11, respectively. Organization and annotation as in Figure 14. b Ribbon view from the ‘back’ of the 
enzyme58 (left, Pol I; right, Pol II). 
 
 
Figure 16. Subunit A12.2 - Structure and sequence comparison. 
a Location of A12.2 (orange) within Pol I (silver) viewed from the side58. The location of the N- and C-ribbon 
domains is indicated. b Structures of Rpb9 (orange) and TFIIS (orange, yellow, green) within Pol II (silver)92, 
viewed as in a. c Subunit A12.2 amino acid sequence alignment. The sequence of yeast S. cerevisiae A12.2 (Sc) 
was aligned with that of the human subunit (Hs), and the N- and C-terminal domains were aligned with their 
counterparts in the Pol II subunit Rpb9 and the Pol II elongation factor TFIIS92, respectively. 
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3.6 Composite active centre and the A49/A34.5 subcomplex 
Whereas Pol II contains a ‘tunable’ active site that is transiently complemented by the C-
ribbon in TFIIS92, Pol I contains a ‘composite’ active site that comprises the A12.2 C-ribbon. 
The C-ribbon occludes the binding site for α-amanitin, explaining why Pol I is less sensitive 
to this toxin than Pol II93. The A12.2 C-ribbon contains a hairpin that reaches the active site 
like the catalytic hairpin of TFIIS, explaining the strong RNA cleavage activity of Pol I8. Pol 
III contains a corresponding C-ribbon in its subunit C1194. The composite active site of Pol I 
and III enables efficient proofreading8,95 and termination96,97. 
The A49/A34.5 subcomplex stabilizes A12.2 (Figure 17a), explaining why it stimulates 
A12.2-dependent8 RNA cleavage11, and why it dissociates after A12.2 deletion98. A49/A34.5 
stretches over the polymerase surface, to reach the AC40 toe domain with its positively 
charged A34.5 C-terminal tail (Figure 17). The mobile A49 tWH domain (Figure 13) may 
close over nucleic acids in the cleft62 to increase transcription processivity8. The A49/A34.5 
subcomplex is related to the Pol II initiation factor TFIIF and to the Pol III subcomplex 
C37/C53, which contain similar dimerization domains located at corresponding positions99-101. 
 
 
Figure 17. Structure and location of the TFIIF-like subcomplex A49/A34.5. 
a Ribbon model of A49/A34.5 on the Pol I core surface viewed from the side58. On the basis of a comparison 
with the Pol-II-TFIIF complex99,100, A49 and A34.5 correspond to TFIIF subunits Tfg1 and Tfg2, respectively. 
The jaw-lobe module is stabilized by the A49/A34.5 subcomplex in a position close to the protrusion. b 
Interaction of A49/A34.5 with Pol I core domains. The view is from the front of the enzyme58. Different Pol I 
subunit domains are coloured as in Figure 14. c 2Fo-Fc electron density (blue mesh, contoured at 1σ) for the 
positively charged A34.5 C-terminal tail that contributes to A49/A34.5 binding61.  
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3.7 Expander and cleft expansion 
Compared to Pol II, the active centre cleft of Pol I is expanded by 8 Å (Figure 18). This 
results from an apparent movement of the two major polymerase modules58, ‘core’ and 
‘shelf’, which mainly comprise subunits A135 and A190, respectively (Figure 18 and Figure 
19). Cleft expansion differs from cleft opening by swinging of the clamp58, and includes a 
relative rotation of the core and shelf modules around an axis through the active site, similar 
to the ratcheting observed for bacterial RNA polymerase bound by an inhibitor protein102 and 
in a paused state103. The expanded cleft is stabilized by the expander, which forms two α-
helices in the active centre (Figure 18c). The expander binds the bridge helix, which is 
unwound in its central region (Figure 18d). Expander residues Asp 1385 and Asp 1388 
sandwich the Pol I-specific residue Arg 1015 in the unwound bridge helix (Figure 18e). The 
expander residue Tyr 1384 inserts between the core and shelf modules, whereas Lys 1377 
reaches the aspartate loop (Figure 18e). 
Cleft expansion changes the active centre that lies at the core-shelf interface (Figure 20a). A 
tilting between the A190 active site domain and the A135 hybrid-binding domain alters the 
conformation of the catalytic aspartate loop and loop β26–β27 that emanate from these 
domains (Figure 20b and c). In the tilted conformation, binding of catalytic metal ions and the 
RNA 3′ end as in Pol II58,104,105 is impossible. Cleft contraction may rearrange the active site 
such that the aspartate loop can bind metal ions with its residues Asp 627, Asp 629 and 
Asp 631, and the A135 loop β26–β27 can bind the RNA 3′ end with its residues Lys 916 and 
Lys 924. Binding of the substrate triphosphate may differ in Pol I because the A12.2 hairpin 
shields the A135 residues Arg 714 and Arg 957, the counterparts of triphosphate-binding Pol 
II residues. The A12.2 hairpin apparently interferes with closure of the triphosphate-binding 
trigger loop104,105, but may bind the triphosphate and position metal ion B, as suggested for the 
TFIIS hairpin during RNA cleavage92. 
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Figure 18. Expanded cleft, expander and unwound bridge helix. 
a Schematic of Pol I structure indicating the four mobile modules (core, shelf, clamp and jaw-lobe) and the two 
peripheral subcomplexes. The view is from the top as in Figure 13, but rotated counter clockwise by 90°. The 
direction of cleft expansion by movement of the shelf module away from the core module is indicated by an 
arrow, and goes along with a 12° rotation between the two modules around the indicated axis through the active 
site. b Expansion of the Pol I active centre cleft. Pol I (black) and Pol II (orange) were superimposed with their 
subunits A135 and Rpb2. The view is as in a. c A novel expander element (raspberry) that is inserted into the 
A190 jaw domain (blue) stabilizes the expanded Pol I cleft and a stretched and unwound bridge helix (green). 
View is from the top58, but rotated by 30° towards the front view. d 2Fo-Fc electron density (blue mesh, 
contoured at 1.3σ) for the bridge helix (green) reveals a central, unwound region. At the bottom, a comparison of 
the bridge helix in Pol II (orange), aligned on the core module side, reveals an expansion by 6Å (arrow). View 
from the front as in Figure 13. e The expander (raspberry) stabilizes the unwound central bridge helix (green). 
View as in c. f Binding of the expander and the DNA–RNA hybrid in the active centre are mutually exclusive. 
Superposition of the Pol I structure with the Pol II elongation complex structure (PDB code 1Y1W) reveals 
clashes between the expander (raspberry) and the DNA template strand (blue) and the RNA transcript (red). 
 
 
Figure 19. Shift in domain positions between Pol I and Pol II. 
Individual domain fragments of Pol I were isolated, superposed onto their counterparts in Pol II and recombined 
to form a ‘pseudo-Pol II’ model. This pseudo-Pol II model was then superposed onto the complete Pol I structure 
over a single common domain (indicated by column headings). The resulting root mean squared deviation 
(r.m.s.d.) Cα (Å) value for every individual domain (indicated by row headings) was calculated using PyMol and 
coloured according to value. 
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Figure 20. Composite active site and A12.2 hairpin. 
a Tilting between the A190 active site domain and the A135 hybrid binding domain. The active site domains of 
Pol I and Pol II were superposed, and the axis of rotation is indicated. The view is approximately from the side58. 
b View of the Pol I active centre from the A135 side towards the clamp. The A12.2 hairpin (orange) forms an 
integral part of the active site. The backbone carbonyl of Asp 627 is flipped compared to its counterpart Asp 481 
in Pol II, and the side chain of Asp 629 is rotated and interacts with Lys 916 and Lys 924 in A135. To catalyse 
nucleotide addition, the aspartate loop must re-establish a metal-binding conformation and move closer to the 
A135 loop b26–b27, which may contribute to binding of metal ion B. c For comparison, the active site in Pol II 
with DNA template (blue), RNA (red), and nucleoside triphosphate substrate analogue (yellow) and the closed 
trigger loop are shown104. 
 
3.8 Connector and polymerase dimerization 
The observed dimeric form of Pol I is established by mutual interactions of the expanded cleft 
of one polymerase with the stalk subcomplex A14/A438,27 of the other polymerase, resulting 
in a handshake (Figure 21). A14/A43 binds to the core enzyme similar to its counterparts 
Rpb4/Rpb7 in Pol II70 and C17/C25 in Pol III10,101. A43 also binds a previously unobserved 
N-terminal α-helix in Rpb6 (Figure 13), explaining the known interaction between A43 and 
Rpb627, and loss of A43 and Rpb6 from Pol I after A14 deletion106. Stalk-mediated Pol I 
dimerization was also observed by electron microscopy60, suggesting that the dimer observed 
in the crystal corresponds to that formed in solution. 
The flexibly linked C-terminal region of A43 folds into a ‘connector’ that invades the cleft of 
the adjacent polymerase (Figure 21). The connector forms a helix (Κ5) that binds along the 
clamp coiled-coil, a β-hairpin (D1–D2) that binds the RNA exit path and the lid, and an acidic 
C-terminal tail that binds the polymerase switch regions 2 and 3. The connector buries 
2,350 Å2 of surface area between the two polymerases, consistent with a role in dimer 
stabilization. The defined structure of the connector and its specific interactions with the 
polymerase cleft argue that connector-mediated polymerase dimerization is functionally 
significant. Consistent with this, the connector cannot be accommodated in a modelled 
contracted state of Pol I, and a C-terminal truncation of A43 that deletes the connector results 
in thermosensitivity in vivo27, and is lethal when combined with other Pol I mutations107. 
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Figure 21. Connector and Pol I dimerization. 
a Structure of the A43 connector and corresponding 2Fo-Fc electron density (blue mesh, contoured at 1σ) and its 
binding to the coiled-coil at the inner side of the clamp (silver). b Structure of the Pol I dimer and its 
stabilization by the A14/A43 subcomplex. One polymerase is shown as a cartoon model, the other in surface 
representation. The connector (blue) invades the cleft of a neighbouring polymerase. 
 
3.9 Transcription regulation 
Pol I dimerization inhibits assembly of the transcription initiation complex because it 
occludes the binding sites for the Pol I initiation factors Rrn327,44 and Rrn744,68,69 (Figure 21). 
Pol I dimers and monomers are in a concentration-dependent equilibrium in vitro (Figure 
22a), but also monomers are predicted to be inactive because the expander overlaps with the 
binding sites for the DNA template strand and RNA (Figure 18f). The expander binds the 
cleft of Pol I in solution, as shown by extensive crosslinking62 (Figure 22c). The expander 
interferes with DNA loading in the active centre, because Pol I shows only weak de novo 
RNA synthesis from a tailed DNA template, in contrast to Pol II, which is much more active 
(Figure 22b). Consistent with a regulatory role of the expander, its deletion does not lead to a 
growth defect in vivo (see Appendix 6.10; Figure 37). 
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Figure 22. Activity of Pol I and re-evaluation of expander crosslinking data. 
a Dynamic light scattering is consistent with a concentration-dependent Pol I dimer-monomer equilibrium in 
solution. Note that the sample with the higher Pol I concentration shows an increased hydrodynamic radius and 
apparent (estimated) molecular mass for the predominant peak by mass that accounts for over 96%. The method 
cannot distinguish monomeric and dimeric species. Thus, the estimated molecular mass observed at 3.5 mg/ml 
Pol I concentration (769 kDa) arises from a mixture of monomers (590 kDa) and dimers (1,180 kDa). b De novo 
RNA synthesis activity on tailed DNA template. Assays were performed as described81 using the DNA template 
shown. After running a 20% acrylamide urea gel, de novo synthesized, radioactive RNA was detected by 
phosphoimaging. c Previously obtained crosslinks62 of the expander element map to the Pol I cleft. Crosslinks to 
A190 and A135 are indicated in grey and wheat respectively. 
 
 
Pol I initiation thus requires (1) release of the connector, to generate monomers and enable 
Rrn3 and Rrn7 binding, (2) release of the expander, to enable DNA loading, and (3) cleft 
contraction, to induce a catalytically competent conformation of the active centre and enable 
RNA synthesis. The resulting mature DNA–RNA hybrid excludes the expander from the 
active centre during elongation, because Pol I is as active as Pol II when provided with a 
mature hybrid (Figure 7). 
This model for regulated Pol I (as illustrated in Figure 23) initiation agrees with known 
functional data. First, Pol I dimers from yeast extracts are inactive in transcription43,51. 
Second, when the connector is unavailable for Pol I dimerization, owing to a fusion with 
Rrn3, Pol I regulation is impaired in vivo16. Third, A43 phosphorylation apparently 
counteracts Pol I dimerization and promotes Rrn3 binding, because (1) A43 binds Rrn327 and 
is phosphorylated in Pol I–Rrn3 complexes45, (2) A43 phosphorylation sites46 at Ser 208, 
Ser 220, Ser 262/263 and Ser 285 are exposed in our structure and face Rrn344, and (3) Pol I 
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dephosphorylation prevents Rrn3 binding and results in low transcription activity45, and 
extracts from non-growing cells lack active Pol-I–Rrn3 complexes43. The same regulatory 
mechanism apparently exists in multicellular eukaryotes, because the expander is well 
conserved, and the connector is partially conserved (Appendix 6.9; Figure 36). Consistent 
with this, inactive human Pol I may be dimeric, whereas human Pol I complexes containing 
the Rrn3 homologue transcription initiation factor-IA (TIF-IA) are active52. Like Rrn3, human 
TIF-IA binds A43108, which may be dephosphorylated during the cell cycle by the Cdc14 
phosphatase that inhibits Pol I109. 
 
 
Figure 23. Model for Pol I initiation regulation. 
The binding site for the initiation factor Rrn3 (green) is occluded in the inactive Pol I dimer (silver; A14 and 
A43 highlighted in red and blue, respectively). Rrn3 is released from inactive Rrn3 dimers44, resulting in active 
Pol-I-Rrn3 complexes. For details compare text. 
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4. Conclusion and Outlook 
4.1 Conclusions 
The Pol I structure enables a detailed structure–function analysis of rRNA production, the 
first step in ribosome biogenesis. It also elucidates the evolution of related cellular RNA 
polymerases. Pol I and III apparently acquired a composite active site for intrinsic RNA 
proofreading, 3′ processing, and chain termination, to enable accurate, high-level production 
of stable RNA products. The composite active site probably impairs extensive RNA 
backtracking because the binding site for backtracked RNA110 is occupied by A12.2. Further 
backtracking may occur during termination and enable cleft expansion and hybrid release, as 
suggested for the bacterial enzyme111 and for Pol III112. By contrast, the tuneable active site of 
Pol II allows for accommodation of backtracked RNA in the pore, Pol-II-specific regulation 
during the elongation phase, and 3′ RNA processing on the polymerase surface by the 
machinery for pre-mRNA cleavage and polyadenylation. 
The most intriguing finding from this work, however, relates to a possible general mechanism 
of transcription regulation. We observe an expanded, inhibited conformation of a eukaryotic 
RNA polymerase that resembles a conformation of bacterial RNA polymerase associated with 
inactive states102,103. Because the polymerase core is highly conserved, all cellular RNA 
polymerases can probably interconvert between an expanded inactive state and a contracted 
active state. State conversion will change the catalytic properties of the enzyme, because the 
active site is formed at the interface between the mobile core and shelf modules. Only the 
contracted state contains the active site in a catalytically competent conformation and binds 
the hybrid tightly. The conversion between polymerase states may be regulated allosterically 
by factors that bind at the interface of the core and shelf modules. Factors may bind in the 
pore, as observed for TFIIS92 and Gfh1102, or near the RNA exit channel, as observed for 
Rrn327,44, the Pol II initiation factor TFIIB that stimulates RNA chain initiation 
allosterically81, and the Pol II coactivator Mediator113. The bacterial regulator catabolite 
activator protein114 and the growth regulator ppGpp also bind at the RNA exit channel, and 
the latter was suggested to influence polymerase activity by modulating the core–shelf 
interface115. 
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4.2 Evaluation of previously obtained structural information on Pol I 
At the beginning of this work, structural information on Pol I included a negative stain 
reconstruction60, a cryo EM structure8, crystal structures of Pol-I-specific subunits8,11 and 
structures of general polymerase subunits within Pol II58. During the work on this thesis, 
crosslinking/MS data that were published from our lab allowed the positioning of Pol-I-
specific subunits on a Pol-II-based homology model62. With the availability of a complete Pol 
I crystal structure, it is now possible to compare the results of the other methods and evaluate 
them. 
Crystal structures of the A49/A34.5 dimerization module and the A14/A43 stalk were most 
helpful during building of the Pol I structure. The overall fold is identical in Sebastian 
Geiger’s great structures that could be positioned by simply placing them roughly inside the 
respective densities and rigid-body-fitting them. Some regions in the respective subunits, 
however, differ from their in-solution structures when bound to Pol I. Firstly, the C-terminal 
tail of A34.5 becomes structured without adopting any secondary structure (Figure 17). This 
explains why the A49/A34.5 subcomplex dissociates upon an A34.5 C-terminal deletion11. 
Secondly, the tWH domain solved in the same study11 is not visible in Pol I. Most likely, it 
becomes structured upon binding of DNA and/or interaction with transcription factors. 
Furthermore, the C-terminal region of the stalk subunit A43 was suspected to be flexible and 
unstructured in solution61. As we found here, it forms the connector element that mediates 
dimerization of two polymerases. Hence, crystal structures of single subunits were correct and 
most helpful but information inferred from them turned out to be incomplete. 
The negative stain EM reconstruction from Patrick Schulz’s group provided a nice envelope 
of the polymerase (Figure 5b)60. Positioning of subunits and general interpretation in this 
study were most accurate despite the rather low resolution and the early publication date. 
Notably, a dimeric state of Pol I was described and is similar to the one observed in the crystal 
structure presented in this work. The comparison of results from both techniques was a great 
control for the results obtained in this study. Of course, detailed description of novel elements, 
such as the expander and the connector and a quantification of cleft opening or its underlying 
core/shelf rotation was impossible from EM data. 
Cryo EM results are somewhat harder to evaluate. Dimers have not been observed in this 
case8. Positions of Pol-I-specific subunits turned out to not entirely correspond to the crystal 
structure. The stalk is positioned in the same spot, but more closely attached to the 
polymerase in the crystal structure. Density of the truncated foot domain is rather strong in the 
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EM envelope and the AC40 toe domain was not visible. The position of the dimerization 
module was interpreted differently in the EM density compared to the crystal structure. In 
cryo EM it was placed on the bottom side of the core module (Figure 5). The massive density 
at this part around the position of AC40/AC19 and the N-terminal region of A135 in the 
crystal structure could result from either a different state of the polymerase under cryo 
conditions, a bound impurity (rather unlikely since not observed in SDS-PAGE), or a partial 
misinterpretation of the polymerase position inside the density since Pol II was used as a 
reference. The same is the case for the density observed for the C-terminal domain of A12.2 
on the outside of the polymerase. Another possible speculation concerning the identity of the 
additional density on the core module that was interpreted as dimerization module and A12.2 
C-terminus could be the following: We discussed the detachment of the expander element 
during transcription since it would otherwise clash with nucleic acids inside the active centre 
cleft. If the cryo EM density resembles an active, contracted, state of the polymerase, the 
expander must be detached from the inside of the cleft but still needs to be close to the jaw. It 
is therefore possible that the expander is observed in a storage position on the outside of the 
polymerase while not being bound inside the cleft, explaining the additional densities in cryo 
EM. 
In contrast to partial disagreements between the cryo EM interpretation and the crystal 
structure, results from crosslinking/mass spectrometry62 agree with the crystal structure very 
well. The position of the dimerization domain and the A12.2 C-terminal domain were similar. 
Even a prediction of the A190 Jaw-insertion being situated inside the cleft was indeed true 
and turned out to be the expander element. 
The general polymerase subunits Rpb5, Rpb6, Rpb8, Rpb10 and Rpb12 are mostly identical 
in Pol II and Pol I. Rpb6 forms an additional N-terminal helix α0 which was discussed earlier. 
Additionally, some further density is visible at the N-terminus of Rpb12 which binds to 
“Domain 2” of AC40. Rpb5, Rpb8 and Rpb10 are otherwise identical in Pol I and Pol II 
despite the occasional visibility of a residue more or less and minor differences in side-chain 
positions. Zinc binding sites of the general subunits are conserved and have Zinc atoms bound 
in all cases. Hence, it can be concluded that the general polymerase subunits carry out the 
same functions and occupy the same position. Nevertheless, some degrees of freedom are 
present which make room for polymerase-specific interactions, such as the Rpb6 helix α0. 
For the above mentioned reasons it can be concluded that a combination of negative stain EM 
and crosslinking/MS data gave rise to the most correct information agreeing with the state 
observed in the crystal structure. This might be helpful for future projects, in case different 
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methods provide alternative results. It was even possible to infer information about a 
different, monomeric, state of the polymerase from crosslinking results and hence extended 
the space available for interpretations. In cryo EM, either sample preparation and freezing 
resulted in the adaptation of an alternate conformation, or technical problems led to alterations 
of the density that do not agree with the crystal structure very well. This also explains the 
impossibility to use a Pol I cryo EM envelope as a model for molecular replacement to solve 
the crystal form A. It might indeed be useful to reprocess EM data using the open 
conformation presented in this study. If technical difficulties played a role during initial 
processing, this would come to light and might be helpful for future EM processing. If no 
differences in the density arise from re-processing, functional conclusions for conformational 
rearrangements could be drawn. 
 
4.3 RNA polymerase I from an evolutionary point of view 
With the availability of a detailed atomic model for a second eukaryotic multi-subunit RNA 
polymerase, it now becomes possible to inspect evolutionary relationships in a new light. 
Firstly, it was confirmed that additional Pol I subunits indeed are built-in transcriptions 
factors. The A49/A34.5 dimerization module resembles the fold of the Tfg1/Tfg2 domains in 
TFIIF as described11. Furthermore, the C-terminal ribbon of A12.2 adopts the fold of its TFIIS 
counterpart as suggested62. 
Most unexpectedly, the AC40 toe domain adopts the fold of the archaeal subunit RpoD that 
binds an iron-sulphur-cluster. Despite displaying a similar fold, the toe is likely not capable of 
binding an iron-sulphur-cluster itself since 3 of the 4 coordinating cysteine residues of RpoD 
are not present in AC40 and a bulky Phenylalanine (F251) occupies the binding pocket. 
Another archaeal feature can be observed in the clamp head region. The first large clamp head 
insertion (A190 helices α3a and α3b; residues 126 – 215; see Figure 14) is situated in the 
same place at which the residues 38 – 82 of the archaeal subunit Rpo13 bind to the 
polymerase (PDB entry 2WAQ)73. Although the double-helical fold is similar in both parts, 
they bind in a ~180° flipped manner. Functional relevance, however, remains unclear. The 
second clamp head insertion displays partial density close to the clamp coiled-coil but cannot 
be built continuously which is why no homologues could be identified. The clamp coiled-coil 
itself is elongated in Pol I when compared to any other polymerase. This might improve 
connector binding due to the enlarged interaction surface available which, however, remains 
speculative. The existence of an enlarged coiled-coil disagrees with the described binding of 
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Spt4/5 to Pol I29, since the Spt4/5 structure bound to a recombinant clamp116 would clash in 
this case. Further in vitro experiments with purified components may be in place to resolve 
this conflict in the Pol I system. 
The absence of large parts of the foot domain in A190 compared to Rpb1 was mentioned 
earlier (Figure 13). Again, it is not clear if there is functional relevance. Potentially, the foot 
domain is used as a binding site for a Pol-II-specific factor which does not need to interact 
with Pol I leading to a degeneration of the element. The mediator complex could be such a 
factor. It would be interesting to mutate the foot domain of Pol II in a Rpb1 shuffle strain in a 
way that is resembles the Pol I foot. This might lead to differences in transcription factor 
binding by Pol II. 
The most interesting novel elements in Pol I, however, are the expander and the connector. 
Both are specific to Pol I and can, in a way, also be regarded as built-in transcription factors, 
similar to the dimerization module, the tWH or the C-terminal ribbon of A12.2. Functional or 
structural equivalents might be present in the Pol II or Pol III transcription systems. 
Modulation of the Core/Shelf interface by different factors has already been speculated about 
(see above). Hence, connector binding might be nothing but a Pol-I-specific, built-in 
inactivation factor that has functional homologues in other systems. Similarly, the expander-
like elements could be present in Pol II transcription factors that contribute to cleft-opening or 
that prevent unspecific DNA interaction inside the cleft. The fact that both elements have not 
been identified in Pol I previously and that they are hardly predictable from amino acid 
sequence information argues that the same could be the case in the Pol II system. 
In general, it seems like Pol I resembles a minimalistic system for transcription that carries 
features from both other eukaryotic polymerases as well as the archaeal polymerase. 
Homologues of factors that only transiently interact with other polymerases are permanently 
built into Pol I. This makes a lot of sense, since a much lower degree of regulation is required 
for Pol I. Pol II transcribes thousands of genes and thus needs to be regulated at a number of 
different levels for which, most likely, different possibilities have emerged throughout 
eukaryotic evolution. In contrast, Pol I just needs to perform one single task: the production of 
rRNA. For this it only needs to be switched on or off, dependent on the cell cycle phase or on 
the availability of nutrients. The permanently bound TFIIS homologue in A12.2 enables rapid 
resolving of problems arising from mis-incorporation of nucleotides or backtracking. It also 
ensures that no sequence mistakes can be made which would otherwise have catastrophic 
effects during ribosome assembly. 
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Furthermore, the same minimalistic tendencies can be observed in the Pol I initiation system. 
The Pol II initiation system is extremely complicated and includes factors like TFIIF, TFIIE, 
TFIIA, TFIIB, TFIID, TFIIH and mediator with a total of almost 100 subunits4. The Pol III 
initiation system is somewhat more compact but still contains numerous factors including the 
7-subunit factor TFIIIC and the trimeric TFIIIB that interact with polymerase as well as 
DNA4. Directly Pol-I-associated initiation factors solely comprise Rrn3 and the core factor as 
the main components in addition to the ubiquitously present TBP and the indirectly 
interacting UBF4. Now, if the core factor is more closely examined, it becomes clear that it 
contains three central elements: the TFIIB-like factor Rrn768, the TPR domain-containing 
Rrn11 and Rrn6 with its large WD40 beta-propeller (inferred from sequence homology and 
domain prediction). Most interestingly, a central part of TFIIIC (τ91) also contains a large 
WD40 beta-propeller117 and interacts with τ131 which itself is a TPR domain protein. Last, 
the central TFIIIB component Brf1 is homologue to Rrn768,69. To summarize: If the Pol III 
initiation machinery is condensed to its most basic parts, one ends up with the homologues of 
the Pol-I-specific core factor of Rrn6, Rrn7 and Rrn11, of which Rrn6 and Rrn7 also have 
distant homologues in the Pol II factors TFIID and TFIIB, respectively. This agrees with the 
Pol I system indeed being the evolutionary most compacted and specialized initiation system 
and thus most ideally suited for structural investigation. 
 
4.4 Future perspectives 
Solving the high resolution structure of Pol I in an inactive, dimeric state with an expanded 
active centre cleft mainly accomplished three things: Firstly, it answered a lot of open 
questions that were discussed throughout this thesis. Secondly, it raised the same number of 
new, more detailed questions that arise from interpretation of the novel data. And finally, it 
opened up the possibility to extend structural studies to polymerase complexes. 
A large number of follow-up projects come to mind. Having the structure firstly allows for 
new attempts on solving the structure of the old crystal form A that C. Kuhn discovered and 
S. Jennebach worked on75,80. Despite low resolution of the data (~5.5Å), conformational 
flexibilities might be visible. Especially the behaviour of connector and expander elements as 
well as the general state of cleft extension (or contraction) will allow for further speculation 
on functional significance. It may also explain why all past attempts to solve the Pol I 
structure from crystal form A were not successful. Initial results look promising but naturally, 
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re-processing of the data takes time and interpretation of low-resolution maps is not straight 
forward. 
In the crystal form C, which has been obtained and solved in this work, soaking of factors is 
hardly possible due to the dimeric state and the very tight packing (solvent content 57%). 
Nevertheless, single or di-nucleotides could be soaked into the crystal to examine very early 
initiation states. They could be accommodated despite the presence of the expander inside the 
active centre cleft. Additionally, the toxin α-amanitin could be soaked at high concentrations 
in order to see if it replaces the A12.2 C-terminal domain or binds differently in Pol I 
compared to Pol II118. 
A second paper describing the structure of Pol I was published by the Müller lab alongside 
this work119. The resolution and data quality was slightly below the work described here. 
Nevertheless, similar elements are observed and similar conclusions drawn, thereby providing 
an unbiased validation for our work and vice versa. Interestingly, their work describes the 
expander element solely as an inhibitor of unspecific DNA binding119 since they present a 
different crystal form that does not have the expander resolved but otherwise is similar to 
ours, i.e. it exhibits the expanded cleft conformation. The authors therefore conclude that the 
expander does not contribute to stabilization of an expanded cleft119. In contrast to that, our 
map quality allowed for residue-specific analysis of expander interactions with the inside of 
the cleft (see Figure 18e, Figure 36 and Appendix 6.9). This suggests a contribution of the 
expander to open-cleft-stabilization. In terms of data interpretation, the absence of an element 
in a low-resolution structure might be a hint, but is somewhat speculative to be used as a sole 
argument for functional significance. Meaning that the expanded-cleft dimer could still be 
formed due to an influence of the expander, but expander detachment follows due to buffer 
conditions or as a crystallization artefact. In order to clarify the role of the expander element, 
additional experiments have hence to be conducted: Firstly, a Pol I version with the complete 
expander knockout needs to be purified and subjected to functional assays, in order to see if 
polymerase function (initiation, elongation and cleavage) are influenced. This version might 
also be subjected to crystallization trials. If the expander stabilizes an expanded cleft, a 
deletion might lead to crystallization in a contracted form. Secondly, a recombinant expander 
could be purified and added to the polymerase in excess. This could lead to an increased 
occurrence of dimers that could be addressed in DLS experiments. Gradual addition of 
recombinant expander to transcription assays could furthermore display its influence on DNA 
binding specificity. 
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Similar to the expander, the connector element should be further investigated. A novel 
knockout of the element starting from A43 residue 251 to the C-terminus should be remade. 
Previous knockouts27 lack a small part of the A43 OB-fold61 in addition to the connector. 
Purified Pol I from a connector deletion strain might show a reduced tendency for 
dimerization, as might be the case for expander knockouts. In general, crystallization of Pol I 
with a contracted cleft should be aimed at, since a number of questions could be answered: 
What happens to the A12.2 C-terminal domain upon cleft contraction? How does the active 
centre actually get rearranged into its active state and becomes capable of performing 
catalysis? What are the dynamics of nucleic acid binding and elongation? Is the dimerization 
module attached identically in the expanded and the contracted state? For this purpose, 
deletion of the expander and the connector are two possible strategies. Furthermore, an 
expander/connector double knockout could be useful. Additionally, dissociation of the stalk, 
eg. by A14 deletion as described107, could drive crystallization in a different form since the 
stalk is not available for crystal contacts and/or dimer formation. Independently, A34.5 could 
be deleted which is accompanied by A49 dissociation from the polymerase11 could give rise 
to a different crystal form. These experiments are under way and might, if successful, lead to 
a number of interesting follow-up results. It is furthermore worthwhile to construct the 
mentioned strains in S. pombe as well as in S. cerevisiae. The respective changes might 
indeed result in the minimal changes that are required for consistent and reproducible 
crystallization of the S. pombe enzyme (see Apendix 6.1). 
Independently of the projects that aim at obtaining the structure of Pol I in an active, 
contracted state, it is now possible to attempt the crystallization of Pol I in complex with 
transcription factors and/or nucleic acids. Considering elongation factors, binding of the 
Spt4/5 complex should be examined, a potential complex checked by EM and probed for 
crystallization. Additionally, recombinant Paf1 complex became available in the lab (Xu et al. 
unpublished). This complex could be bound to Pol I, potentially in the presence of Spt4/5 
similarly to a recent study in Pol II32,33. This large elongation factor complex could be 
subjected to EM and crosslinking/MS studies to examine its general architecture. 
But most interestingly, the initiation complex can now be targeted. Crystallization of a Pol I / 
Rrn3 complex can be attempted since tight binding was established44 and phase information 
can now be obtained by molecular replacement with the Pol I structure. An extension to the 
minimal pre-initiation complex by addition of recombinant CF is the next step. CF expression 
and purification has been established together with T. Gubbey throughout this work77. We 
also managed to form this complex and subject it to negative stain EM (M. Kock) and 
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crosslinking/MS analysis in collaboration with F. Herzog. Results will enable the positioning 
of CF elements that can be modelled and the A49 tWH domain in relation to CF. This hybrid 
approach allows for a high confidence positioning and combines the methods that were 
proven to be most reliable in the Pol I field (see above). The complex itself can be further 
extended by a DNA/RNA hybrid scaffold and TBP to form the complete Pol I PIC. The 
strong stability of this complex also makes it a prime target for crystallization, since it 
resembles the minimal, evolutionary conserved polymerase initiation machinery. This project 
can furthermore be complemented by the S. pombe Pol I system, that became available during 
the course of this study (see Appendix 6.1). 
In terms of the initiation complex, it might also be worth to break it down into its minimal 
domains. A minimal Rrn7 construct could be bound to the polymerase. The Rrn7-N210 
constructs (see Materials Table 10) comprises the TFIIB-like elements and the N-terminal 
cyclin fold, as far as can be inferred from homology analysis68. It thus resembles the TFIIB 
construct that has been successfully crystallized together with Pol II81 and might be able to 
bind to Pol I on its own. Other CF domains, such as the WD40 beta propeller of Rrn6 of the 
TPR domain of Rrn11 can be examined by crystallography, especially considering that Rrn11 
in S. pombe is enormously truncated and contains only the minimally conserved TPR part. In 
any case, partial structures would be helpful to later solve the initiation complex. 
In a different line of investigation, the cleft expansion and contraction demonstrated on the 
dimeric structure of Pol I presented in this work should be addressed. Does Pol II indeed 
perform a similar movement under specific circumstances? Does the same hold true for 
archaeal polymerase and for Pol III? Or might there be an evolutionary relationship between 
bacterial polymerase and Pol I that restricts the explained core-shelf-movement to the two of 
them? To answer these questions, it is constantly aimed at solving novel structures of 
polymerases in different states and with different transcription factors bound. 
To summarize, the structure of Pol I presented here is the conclusion of an almost 10-year 
long quest for the right crystal form. The description of novel elements and a dimeric state 
with an extended active centre cleft furthermore elaborated a novel theory of the regulation of 
Pol I in specific and of all polymerases in general. 
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6. Appendix 
6.1 Schizosaccharomyces pombe RNA polymerase I 
6.1.1 Construction and cultivation of S. pombe strains with tagged Pol I subunits 
At the beginning of this work, several strategies were designed which all aimed at obtaining a 
novel crystal form for RNA polymerase I. Work on crystal form A by C. Kuhn75 and S. 
Jennebach80 showed that the originally obtained crystals of S. cerevisiae Pol I were not 
suitable for solving its structure. Around the same time, a study from the lab of R. Kornberg 
presented the crystal structure of S. pombe Pol II71. This proved that, in principle, the structure 
of multi-subunit RNA polymerases can be solved from other organisms, especially S. pombe. 
Therefore, the initial idea for this work was to establish a protocol that enables the 
purification of Pol I from the fission yeast S. pombe and use it for crystallization trials. In 
detail, this means that S. pombe strains with tagged Pol I needed to be constructed, their large 
scale fermentation established and a purification protocol developed. 
All in all, the subunits of Pol I are largely conserved between S. cerevisiae and S. pombe (see 
Table 15). The most striking difference is the size of the subunit A43. Its charged C-terminal 
domain that we term “connector” (see Results) is lacking entirely in S. pombe. Thus, the 
molecular weight of the 14-subunit enzyme in S. cerevisiae is roughly 20 kDa larger than in S. 
pombe (589.6 kDa and 568.5 kDa, respectively). Regarding its biochemical features, the S. 
pombe enzyme is predicted to have a slightly higher PI (6.55 compared to 6.25 in S. 
cerevisiae; calculated with the program “Protparam” of the “Expasy” toolkit on 
www.expasy.org). The sequence identity between Pol I of both organisms is 48,6%. It is 
therefore likely that the enzyme is similar but could display different surface properties which 
might influence crystallization. 
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Table 15. Comparison of Pol I subunit sizes in S. cerevisiae and S. pombe 
 
Subunit No. of residues in S. cerevisiae 
No. of residues in 
S. pombe 
Sequence 
identity [%] 
A190 1664 1689 50 
A135 1203 1227 61 
A49 415 425 27 
A43 326 173 34 
AC40 335 348 56 
A34.5 233 251 17 
Rpb5 215 210 56 
Rpb6 155 142 49 
A14 137 147 13 
Rpb8 146 125 43 
AC19 142 125 48 
A12.2 125 119 57 
Rpb10 70 71 71 
Rpb12 70 63 38 
 
 
As a strain, the wild-type like 972h- was used, from which Pol II was previously purified and 
crystallized71. Taking into account that a bulky tag for purification might hinder 
crystallization, a rather small tag was chosen: a C-terminal Flag- coupled to a 10xhistidine 
tag. The Flag-tag (DYKDDDDK) is used linker as well as an epitope tag to follow the 
polymerase fractions throughout the purification steps. The 10xhistidine tag was chosen to 
enable a high-affinity Ni-NTA purification. As tag locations, the three Pol-I-specific subunits 
A14, A49 and AC40 were used. While A14 and A49 are Pol-I-specific, peripheral subunits, 
AC40 is shared with Pol III. Genomic insertion constructs were designed, containing the 
following elements (see Figure 24a): 5’ – homology to the 3’ end of the Pol I subunit – Flag-
tag – 10xHis tag – Stop codon – G418 resistance cassette – homology to the terminator 
sequence of the Pol I subunit – 3’. The respective constructs were ordered (Gene Art) and 
amplified from the delivered plasmids. Genomic insertion into S. pombe was performed as 
described for S. cerevisiae (see Methods). Correct insertion was tested by amplification of the 
3’ end of modified genes (see Figure 24a). For all three insertion-constructs, positive clones 
were obtained (Figure 24b). Since it could not be excluded that the inserted tags have an 
influence on polymerase assembly or function, growth curves of 500 ml cultures were 
recorded (Figure 24c). All constructed strains were viable and none of the Pol I tags lead to a 
growth defect. Slight fluctuations are more likely to originate from experimental error than 
from significant growth defects. 
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Figure 24. Generation S. pombe strains with tagged Pol I subunits. 
a Design of constructs for genomic insertion and location of control primers to validate correct insertion. The 
same strategy was used for construction of all three Pol-I-tag strains. b Result of control PCRs from genomic 
DNA of the established strains shows a product in 2 of 3 clones for each strain. Sybr-safe stained 1% agarose gel 
with 1kB marker. c Growth curves of the constructed strains in comparison to the wild type strain show no 
growth defect during the first 12 hours. 
 
 
 
In order to obtain cell masses that enable the purification of a sufficient amount of Pol I from 
endogenous expression levels, large scale fermentation of S. pombe was inevitable. The 
establishment of a respective protocol, however, was not straight forward and included trial-
and-error based optimization of parameters from classical S. cerevisiae fermentation as well 
as S. pombe growth in culture flasks. The protocol that was finally established is detailed in 
the Methods section of this work.  
 
6.1.2 S. pombe Pol I - purification and activity 
Resulting from completion of the first stages of this work, S. pombe strains with tagged Pol I 
subunits could be cultivated in large quantities: a 200 litre fermenter yielded up to 2.5 kg of S. 
pombe cells. Even though the handling of S. pombe is somewhat different to S. cerevisiae, the 
purification protocol for Pol I could in principle be maintained. As shown in a western blot in 
Figure 25a, the first steps could be adapted with little to no buffer changes. For anion 
exchange and cation exchange (MonoQ and MonoS, respectively), gradients were maintained  
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from the S. cerevisiae protocol, but elution profiles and contaminant peaks changed as well as 
the elution properties of the polymerase (see Figure 25b-d). The MonoS cation exchange step 
was not as important for the S. pombe protein as for its S. cerevisiae counterpart. The step 
Figure 25. Purification of S. pombe Pol I. 
a The first steps of the purification are cell lysis, 
two centrifugation steps, dialysis and Ni-NTA 
affinity chromatography. The Flag-tag of the A14 
subunit is followed during these steps via an anti-
flag western blot detected with secondary HRP 
antibody. b-d Elution profiles of the columns run 
throughout the purification. The respective elution 
parameters are indicated. e Coomassie-stained 
SDS-PAGE of S. pombe Pol I after SEC. Subunit 
identities are indicated and were confirmed by 
mass spectrometry. 
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rather polishes the purity, comparable to the size exclusion step. However, the overall yield of 
S. pombe Pol I was mostly higher than from S. cerevisiae. Therefore, the loss of protein 
associated with performing the MonoS step could be tolerated and the step was maintained. 
After the final Superose6 size exclusion step, all Pol I bands are visible on a Coomassie-
stained SDS-PAGE (Figure 25e). The presence of all 14 subunits was confirmed by mass 
spectrometry. A purification from three pellets (about 500 g yeast) yielded up to 2.5 mg 
protein if the MonoS step was included. For establishment, the A14-tag strain was used. 
Later, the AC40-tagged strain appeared to have slightly higher yield without increasing Pol III 
contamination and was thus used from that point on. 
 
 
 
 
 
Figure 26. Elongation/cleavage assay 
of S. pombe Pol I. 
A standard elongation/cleavage assay 
was performed with Pol I from S. 
pombe with the displayed scaffold was 
performed as described8,80. An 
elongation is clearly visible as is a 
partial cleavage activity. 20% urea 
PAGE, fluorescence detection. 
Following establishment of a reproducible protocol for 
large scale Pol I purification from S. pombe, the second 
phase of the project was completed. Nevertheless, before 
crystallization trials were initiated, it needed to be 
ensured that the purified complex is stable and can carry 
out its designated task: transcribing RNA from a DNA 
template and cleave it, if required. For this reason, 
elongation and cleavage assays were performed with 
fluorescently labelled RNA annealed to a tailed template 
DNA-scaffold (Figure 26).  
The assay was carried out exactly as described8,80. It is 
clearly visible, that upon addition of S. pombe Pol I and 
NTPs elongation as well as cleavage of RNA take place. 
Thus, it can be concluded that the purified Pol I from S. 
pombe is active and must hence be in its natural state, not 
being damaged by the purification procedure. Therefore, 
the protocol can be used to obtain material that is suitable 
for crystallization trials. 
 
6.1.3 Attempts to crystallize S. pombe Pol I 
Being able to purify active S. pombe Pol I in sizable quantities was a prerequisite for 
performing large scale crystallization trials. All screens that were available at the 
crystallization facility of the MPI for Biochemistry (Martinsried, Germany) were tested with 
the purified S. pombe Pol I. Additionally, drop ratios, Pol I concentrations and temperatures 
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were screened. During the first experiments, initial crystals were obtained in two related PEG 
3350 conditions (Figure 27a and b) from a number of different preparations. Unfortunately, 
those could not be reproduced during later stages of the project. It can be speculated, that 
most likely purification protocols and experience in polymerase handling had improved and 
advanced the purity of proteins during the course of the experiments. Hence it is likely that 
either a contaminant crystallized and formed the crystals in Figure 27a and b, or, that the 
presence of contaminants (such as residual proteases) fostered the crystallization of S. pombe 
Pol I. Regardless, the initial crystals diffracted X-rays to low resolution (Figure 27f). It was, 
however, not possible to determine space group parameters from that. Other crystals of S. 
pombe Pol I were obtained (Figure 27c-e), but it was either impossible to improve them (d 
and e) or reproducibility was again an issue (c). 
 
 
Figure 27. Crystallization of S. pombe Pol I. 
a and b Rod-shaped crystals that were obtained from early Pol I preparationss in related conditions. 
c – e Additional crystal forms and their respective conditions. For details see text. f Diffraction analysis of the 
crystals from a. The diffraction clearly originated from protein, but it was impossible to conclusively index the 
data from the obtained frames. 
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Throughout the project, another crystal form of S. pombe Pol I appeared at different stages but 
always from perfectly pure polymerase samples, thus minimizing the possibility that a 
contamination played a role in this case. These crystals in the PEG 4000 condition (15% (w/v) 
PEG 4000, 100 mM Tris pH8.5, 200 mM MgCl2 in 100 nl drops set up with 8 mg/ml Pol I at 
20°C; Figure 28) did not diffraction in the PX scanner, which records single frames of the 
crystals while they are still inside the crystallization drop. Therefore, the crystals cannot 
consist of salt but must be made of protein. The crystals of this form, however, were 
extremely fragile and mostly embedded into a protein skin on the top of the drop which tends 
to build up at high protein concentrations. This made it impossible to fish them from small 
screening drops and analyse their X-ray diffraction properties. If the project was to be 
continued at any point in time, the experimentator’s recommendation would be to start off 
from these crystals and try to optimize them.  
After the consistent occurrence of reproducibility issues with the discussed S. pombe Pol I 
crystal forms, it became clear that untreated Pol I does not crystallize easily. It was therefore 
attempted to alter the surface properties of the enzyme and thereby potentially influence its 
ability to crystallize. For this purpose, several strategies were probed: (1) nucleic acid 
scaffolds of different sizes and compositions were added, (2) it was attempted to bind the 
initiation factor Rrn3 from S. pombe and thereby stabilize the position of stalk subunits, (3) 
subunits were dissociated chemically or by genomic deletion, and (4) exposed surface loops 
of the native enzyme were digested with different proteases. Protein originating from either of 
these attempts was subsequently subjected to high throughput screens at the crystallization 
facility of the MPI for Biochemistry (Martinsried, Germany). However, it was impractical to 
screen all ~20,000 available conditions for each of the experiments, for different 
concentration and drop ratios etc. Hence, the so-called “Pol-Screens” were designed. They 
include conditions at which multi-subunit polymerases were crystallized before (S. cerevisiae 
Pol II, S. pombe Pol II, bacterial polymerase, etc.). Additionally, conditions for crystallization 
 
 
Figure 28. S. pombe Pol I 
crystals in a PEG 4000 
condition. 
The same drop is displayed 14 
and 24 days after setup. After two 
weeks, relatively large, needle-
like crystals grew and did not 
diffract in a salt-like manner. 
Handling and reproducibility of 
those crystals proved challenging. 
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of Pol II complexes with initiation factors and for the mitochondrial RNA polymerase were 
added. For all of these, a gradient of precipitant concentration is covered in the screens. This 
makes it relatively easy to judge if a novel polymerase sample is suitable for crystallization 
and at the same time covers a range of likely conditions. 
The results of the different strategies listed above were as follows: 
(1) The S. pombe RNA polymerase I bound all nucleic acid scaffolds that were provided to it, 
as determined by the A280/A260 ratio in analytical size exclusion experiments (data not 
shown). However, none of the bound scaffolds did influence its tendency to crystallize 
consistently. 
(2) The initiation factor Rrn3 was cloned from S. pombe, expressed recombinantly and 
purified for the first time. Unfortunately, the expressions were highly contaminated with 
chaperones that migrate identically to Rrn3 in SDS-PAGE. The small amount of protein that 
could be purified did not interact with Pol I as strongly as it was shown for its S. cerevisiae 
counterpart44. Therefore, at the time being it was not possible to form a S. pombe Pol I / Rrn3 
complex that could be subjected to meaningful crystallization trials. If follow-up studies were 
to be made, it might be worthwhile to prepare S. pombe Pol I in the presence of phosphatase 
inhibitors. A phosphorylated version of Pol I might bind Rrn3 more easily, as suggested in 
other studies44. 
(3) Chemical dissociation of the peripheral Pol I – subunit complex A49/A34.5 was described 
in the S. cerevisiae system8. The same protocol was performed on S. pombe Pol I. However, 
two problems made it impossible to transfer the procedure. Firstly, the S. pombe enzyme 
reacted much stronger and dissociated heavily. Secondly, the fraction of polymerase that 
actually lost A49/A34.5 and remained stable showed a reduced binding to MonoQ anion 
exchanger. This is most likely due to the absence of the charged C-terminal region of the stalk 
subunit A43 in S. pombe. Thus, a different re-purification method has to be chosen if 
reattempted. MonoS cation exchange is most likely not applicable, since one of the regions 
mostly responsible for MonoS resin binding is the lysine-rich C-terminal tail of A34.5, which 
is removed alongside A49. Size exclusion would remove the urea and might thus lead to 
partial reattachment of dissociated subunits. If performed under urea conditions, a second size 
exclusion would be necessary to remove urea independently, since it might influence 
experiments to follow (such as crystallization trials). A Ni-NTA affinity purification might be 
of use but would again leave the sample contaminated with imidazole. 
Since the chemical dissociation of Pol I subunits in large scale was unsuccessful, purification 
of Pol I from S. pombe strains with mutated subunits was considered. During the course of 
 
 
87 
 
this work, a study from the lab of Oliver Gadal reported S. pombe strains with deleted A34.5 
and A49 subunits34. Those strains were kindly gifted to us and a A190-Flag/10xhistidine tag 
was introduced to the A34.5 deletion strain. The strain itself shows a slow-growth phenotype 
and does not reach cell densities of wild type S. pombe strain under laboratory conditions. 
Nevertheless, Pol I could be purified from this strain with the exception of the MonoS cation 
exchange step (due to the lack of A34.5 lysine-rich tail). The purified Pol I version is termed 
“Pol IΔ” and not only entirely lacks A34.5 but also A49 (Figure 29). Thus, genomic 
construction of a polymerase version with different surface properties was successful in S. 
pombe for the first time. However, Pol IΔ displayed other impurities and a partial 
contamination with Pol III as identified by mass spectrometry. Additionally, other subunits 
were substoichiometric in the Pol IΔ variant and the overall yield was extremely low (about 
100 µg Pol IΔ from 350 g yeast). Crystallization screens were carried out nevertheless but did 
not yield hits in the initial standard screens and the Pol-screens. 
(4) For the crystallization of recombinant proteins, it has become a standard procedure to 
partially digest single proteins or complexes and analyse the dynamics of the reaction to 
identify stable fragments. These fragments can then expressed separately and subjected to 
further rounds of digestion and finally might be suitable for crystallization61. For 
endogenously purified multi-subunit complexes such as Pol I, however, this strategy is not 
applicable due to enormous cloning efforts and lethality issues. Thus, an adaptation of the 
strategy was applied in this case. Firstly, in-drop digest of S. pombe Pol I was performed 
similarly to the procedure that lead to solution of the structure of human mitochondrial RNA 
polymerase120,121. For Pol I, this did not improve crystallization behaviour. Secondly, a 
limited digest with different proteases was performed and stopped after one hour by the 
addition of an access of protease inhibitor mix. Digested polymerase was subsequently 
 
 
Figure 29. Purification of S. pombe 
Pol IΔ. 
Pol I from a S. pombe strain with a 
genomic deletion of A34.5 and an 
AC40 Flag/His-tag was purified 
(MonoS cation exchange skipped). The 
subunit-complex A49/34.5 dissociated 
completely and is not visible in 
Coormassie stained SDS-PAGE. Pol IΔ 
displays an increased amount of 
contaminating bands 
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gelfiltered to remove proteases and their inhibitors, and subjected to functionality assays as 
well as crystallization trials. Figure 30a compares the analytical size exclusion profile of an 
untreated S. pombe Pol I sample with a subtilisin digestion variant (SDS-PAGE of both is 
displayed in b). The profiles and band patterns show that, following proteolytic digestion, the 
polymerase stays assembled but loses a large portion of its molecular weight. Hence, the 
removal of surface parts was likely successful. Similar to subtilisin digestion, the protocol was 
also successful with the proteases trypsin and chymotrypsin. All proteases gave rise to a 
distinct band pattern in the digested polymerases (Figure 30c). To test if the stubbed 
polymerases are still functionally active, standard elongation/cleavage assays were performed. 
Whereas elongation seemed to be slightly impaired, all digestion variants did elongate the 
RNA and were capable of product cleavage (Figure 30d). 
 
 
Figure 30. Proteolytic digest of S. pombe Pol I. 
a Size exclusion chromatograms of undigested and subtilisin digested polymerase. An elution shift of 1.1 ml 
hints at massive removal of unstructured parts, whereas the polymerase core seems to be stable since the 
digestion variant still elutes in a single peak. b Coomassie-stained SDS-PAGE of the peaks from a. c Difference 
in gel band patterns of Pol I in a Coomassie-stained SDS-PAGE following proteolytic digest and SEC. d All 
digestion variants are still active as shown by an elongation/cleavage assay. Fluorescence detection of 20% urea 
PAGE. 
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Subjected to crystallization screens, the subtilisin and trypsin digestion variants did not 
produce any hits. In contrast, the chymotrypsin digest crystallized after 10-15 days at a Pol I 
concentration of 5 mg/ml in 30% Jeffamine ED-2001 pH 7.0 and 100 mM Hepes pH 7.0 
(Figure 31a-c). Crystals grew at 20°C in 100 nl drops for 5 – 10 days and were very small but 
seemed to be clean ellipsoids of up to 25 µm length. Reproduction proved successful in every 
3rd trial most likely due to sample inhomogeneity resulting from up-scaling issues with the 
digestion protocol. One successful reproduction of the digestions crystals yielded needle-like 
crystals (Figure 31d) after over a month. The Jeffamine drops, however, dry out quickly and 
crystals could not be removed from protein skin to subject them to X-ray diffraction analysis. 
 
 
 
6.1.4 Conclusion of the S. pombe Pol I project 
The goal of this work was to produce a novel crystal form of Pol I from which its structure 
can be solved. For this purpose, using the S. pombe enzyme as an alternative for S. cerevisiae 
was the central strategy. Initial results were positive: a fermentation and purification protocol 
could be established and first crystals were obtained rapidly. Later on, however, 
reproducibility became a central issue. Quality of the different fermentations and purifications 
seems to be an issue that can hardly be quantified. Nevertheless, comparable problems appear 
to occur also for S. cerevisiae Pol II if complex with transcription factors: Some preps 
produce high quality crystals whereas others don’t diffract to high resolution at all. In the case 
of S. pombe Pol I, the difference, however, was wether the protein would crystallize at all. 
Figure 31. Crystallization of a chymotrypsin-digested S. pombe Pol I 
variant. 
a – c Time course of a Jeffaminne drop shows the appearance of initial 
crystals from digested polymerase. d Reproducibility is again an issue 
due to upscaling issues with digestion protocol. In rare cases, the 
crystals from c could be obtained but not harvested. 
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The subunit A43 was always present in preparations but tended to be substoichiometric. Also, 
it migrated at much higher apparent molecular weight in SDS-PAGE than its theoretical 
molecular weight of 21 kDa would suggest. This hints at the occurrence of posttranslational 
modifications. Beside the known phosphorylation other modifications such as sumoylation, 
ubiquitinylation or acetylation could take place. In the human system, for example, 
acetylation of the A49 homologue has been recently reported to play a regulatory role122. 
Similarly, the absence of the connector element in S. pombe could result in the need for a 
different level of A43 regulation by posttranslational modification. By purifying a mixture of 
modified and unmodified complexes, a heterogeneity would be introduced, which could 
explain the inconsistency in S. pombe Pol I crystallization behaviour. 
Nevertheless, despite failure to consistently crystallize Pol I from S. pombe, the work on it 
resulted in a number of benefits: 
 
(1) This is the first time that RNA polymerase I from an organism other than S. cerevisiae 
could be purified in crystallization grade quality and quantity. 
(2) Pol-Screens to easily probe crystallization behaviour of novel samples have been 
designed for this project and are now widely used also for Pol-II-related projects and 
ultimately were an integral part of solving the structure of S. cerevisiae Pol I, since 
they gave rise to the first hit of crystal form C. 
(3) A novel system for functional and structural projects was established. Since 
crystallization is dependent on small influences, Pol I complexes of S. pombe could be 
superior to their S. cerevisiae homologues and thus provide an easily accessible 
secondary system for further generations of PhD students working on polymerase 
projects. Similar experiences have been made with the “mediator head” in our lab123. 
For functional analysis, in vitro data from a second organism can be of importance as 
controls just as well. 
(4) Experience in handling of polymerases seems to be of great importance to ensure 
consistency. Therefore, establishing a new system was the best possible training and 
provided all the practical experience necessary for solving the structure of a 
polymerase and thus laid a solid groundwork for the work carried out in the S. 
cerevisiae system. 
 
With this, the project can be judged as a partial success despite the inability to solve the 
structure of S. pombe Pol I as of now.  
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6.2 Scripts for crystallographic data processing 
6.2.1 XDS script for data integration 
!*****************************************************************************  
! XDS.INP used on crystal CE188 for the PILATUS 6M pixel detector at SLS  
!*****************************************************************************  
 DETECTOR=PILATUS         MINIMUM_VALID_PIXEL_VALUE=0 OVERLOAD=1048500  
 SENSOR_THICKNESS=0.32  
 NX=2463 NY=2527 QX=0.172  QY=0.172  !PILATUS 6M  
 
DIRECTION_OF_DETECTOR_X-AXIS= 1.0 0.0 0.0  
DIRECTION_OF_DETECTOR_Y-AXIS= 0.0 1.0 0.0  
TRUSTED_REGION=0.0 1.41  
 
!====================== JOB CONTROL PARAMETERS ===============================  
!JOB= XYCORR INIT COLSPOT IDXREF !THIS JOB WAS USED IN A FIRST RUN FOR INDEXING  
JOB= DEFPIX XPLAN INTEGRATE CORRECT  
 
!====================== GEOMETRICAL PARAMETERS ===============================  
 
ORGX=1250.0  ORGY=1238   !Detector origin (pixels)  
DETECTOR_DISTANCE= 575   !(mm)  
 
ROTATION_AXIS= 1.0 0.0 0.0  
OSCILLATION_RANGE=0.1 
 
X-RAY_WAVELENGTH=  1.00000  
INCIDENT_BEAM_DIRECTION=0.0 0.0 1.0  
FRACTION_OF_POLARIZATION=0.99  
POLARIZATION_PLANE_NORMAL= 0.0 1.0 0.0  
 
!======================= CRYSTAL PARAMETERS =================================  
SPACE_GROUP_NUMBER=0   !0 is used for unknown crystals  
FRIEDEL'S_LAW=TRUE.  
 
!==================== SELECTION OF DATA IMAGES ==============================  
 NAME_TEMPLATE_OF_DATA_FRAMES=~/ce188/ce188_1_0????.cbf  
 DATA_RANGE=1 5300  
 BACKGROUND_RANGE=1 20  
 
!====================== INDEXING PARAMETERS =================================  
SEPMIN=4.0  
CLUSTER_RADIUS=2  
 
!============== DECISION CONSTANTS FOR FINDING CRYSTAL SYMMETRY =============  
MAX_CELL_AXIS_ERROR=0.03 ! Maximum relative error in cell axes tolerated  
MAX_CELL_ANGLE_ERROR=2.0 ! Maximum cell angle error tolerated  
 
TEST_RESOLUTION_RANGE=8.0 4.5  
MIN_RFL_Rmeas= 50 ! Minimum #reflections needed for calculation of Rmeas  
MAX_FAC_Rmeas=2.0 ! Sets an upper limit for acceptable Rmeas  
 
!================= PARAMETERS CONTROLLING REFINEMENTS =======================  
REFINE(INTEGRATE)= BEAM ORIENTATION CELL  
!REFINE(CORRECT)=DISTANCE BEAM ORIENTATION CELL AXIS  
 
!================== CRITERIA FOR ACCEPTING REFLECTIONS ======================  
VALUE_RANGE_FOR_TRUSTED_DETECTOR_PIXELS= 6000 30000  
 
INCLUDE_RESOLUTION_RANGE=70.0 2.8  
 
MINIMUM_ZETA=0.05  
 
!============== INTEGRATION AND PEAK PROFILE PARAMETERS =====================  
 
NUMBER_OF_PROFILE_GRID_POINTS_ALONG_ALPHA/BETA=13  
 
!=========== PARAMETERS DEFINING BACKGROUND AND PEAK PIXELS =================  
 
MINIMUM_NUMBER_OF_PIXELS_IN_A_SPOT=3  
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6.2.2 XSCALE script for the combination of five datasets from four crystals 
0-DOSE_SIGNIFICANCE_LEVEL=0.50  
OUTPUT_FILE=merge_zero.hkl  
FRIEDEL'S_LAW=TRUE  
MERGE=TRUE  
STRICT_ABSORPTION_CORRECTION=FALSE  
 
INPUT_FILE= ../ce188/xds_2/XDS_ASCII.HKL  
    INCLUDE_RESOLUTION_RANGE= 40 2.8  
    CRYSTAL_NAME=ce188_2  
 
INPUT_FILE= ../ce188/xds/XDS_ASCII.HKL  
    INCLUDE_RESOLUTION_RANGE= 40 2.8  
    CRYSTAL_NAME=ce188_1  
 
INPUT_FILE= ../ce201/xds/XDS_ASCII.HKL  
    INCLUDE_RESOLUTION_RANGE= 40 2.8  
    CRYSTAL_NAME=ce201  
 
INPUT_FILE= ../ce259/xds_b/XDS_ASCII.HKL  
    INCLUDE_RESOLUTION_RANGE= 40 2.8  
    CRYSTAL_NAME=ce259_b  
 
INPUT_FILE= ../ce152/xds/XDS_ASCII.HKL  
    INCLUDE_RESOLUTION_RANGE= 40 2.8  
    CRYSTAL_NAME=ce152  
 
6.2.3 XSCALE – Selected output parameters 
 THE DATA COLLECTION STATISTICS REPORTED BELOW ASSUMES:  
 SPACE_GROUP_NUMBER=    1  
 UNIT_CELL_CONSTANTS=   122.74   139.02   209.55 108.060  95.403 93.848  
 ALL DATA SETS WILL BE SCALED TO ../ce188/xds_2/XDS_ASCII.HKL  
 
 ******************************************************************************  
                    READING INPUT REFLECTION DATA FILES  
 ******************************************************************************  
 
 NUMBER OF UNIQUE REFLECTIONS IN FILE "REMOVE.HKL"     163  
 
 DATA    MEAN       REFLECTIONS        INPUT FILE NAME  
 SET# INTENSITY  ACCEPTED REJECTED  
   1  0.2659E+02   643001    316 ../ce188/xds_2/XDS_ASCII.HKL  
   2  0.2835E+02  1638774    769 ../ce188/xds/XDS_ASCII.HKL  
   3  0.8544E+01   765475    479 ../ce201/xds/XDS_ASCII.HKL  
   4  0.2161E+02   380492    259 ../ce259/xds_b/XDS_ASCII.HKL  
   5  0.1127E+02   770320    352 ../ce152/xds/XDS_ASCII.HKL  
 
 ******************************************************************************  
                OVERALL SCALING AND CRYSTAL DISORDER CORRECTION  
 ******************************************************************************  
 
      CORRELATIONS BETWEEN INPUT DATA SETS AFTER CORRECTIONS  
 
 DATA SETS  NUMBER OF COMMON  CORRELATION   RATIO OF COMMON B-FACTOR  
  #i   #j     REFLECTIONS     BETWEEN i,j  INTENSITIES (i/j) BETWEEN i,j  
 
    1    2      137844           0.966            1.0060 -0.1070  
    1    3      105989           0.955            1.0063 0.0559  
    2    3      106853           0.944            1.0065 0.0198  
    1    4       84571           0.918            0.9930 -0.5293  
    2    4       87131           0.935            1.0109 -0.5341  
    3    4       76583           0.899            1.0267 -1.1212  
    1    5      114809           0.929            0.9950 0.2459  
    2    5      115454           0.943            0.9855 0.2195  
    3    5       94390           0.915            0.9767 0.4377  
    4    5       76769           0.959            1.0379 -0.1888  
 
 SUBSET OF INTENSITY DATA WITH SIGNAL/NOISE >= -3.0 AS FUNCTION OF RESOLUTION  
 RESOLUTION     NUMBER OF REFLECTIONS    COMPLETENESS R-FACTOR R-FACTOR COMPARED I/SIGMA   R-meas  CC(1/2)  Anomal  SigAno   Nano  
   LIMIT     OBSERVED  UNIQUE  POSSIBLE     OF DATA   observed expected                                      Corr  
 
    12.52       40590    3478      3597       96.7%       8.3% 10.8%    40590   30.37     8.7%    99.7*   -13    0.676    3402  
     8.85       86692    6567      6577       99.8%       9.3% 11.4%    86692   30.16     9.6%    99.8*   -17    0.629    6538  
     7.23      105359    8480      8494       99.8%      11.0% 12.8%   105359   24.10    11.5%    99.7*   -17    0.686    8432  
     6.26      134659   10110     10123       99.9%      13.5% 14.9%   134659   20.42    14.1%    99.5*   -19    0.691   10096  
     5.60      155578   11348     11354       99.9%      15.0% 16.4%   155578   18.72    15.6%    99.5*   -19    0.680   11331  
     5.11      160339   12647     12666       99.8%      15.6% 16.8%   160339   17.34    16.2%    99.4*   -19    0.685   12604  
     4.73      179718   13775     13785       99.9%      16.1% 17.1%   179718   17.17    16.8%    99.4*   -23    0.673   13749  
     4.43      198177   14751     14759       99.9%      17.1% 18.0%   198177   16.51    17.7%    99.4*   -22    0.677   14727  
     4.17      210053   15700     15712       99.9%      19.1% 20.0%   210053   14.87    19.9%    99.2*   -19    0.690   15670  
     3.96      211043   16572     16583       99.9%      22.7% 23.5%   211043   12.52    23.6%    98.8*   -18    0.701   16514  
     3.78      226004   17508     17527       99.9%      27.7% 28.7%   226004   10.67    28.8%    98.5*   -18    0.713   17474  
     3.61      244122   18170     18183       99.9%      35.4% 36.4%   244122    9.15    36.9%    97.9*   -16    0.729   18133  
     3.47      259891   19069     19093       99.9%      44.4% 45.7%   259891    7.76    46.1%    97.0*   -14    0.736   19043  
     3.35      261803   19820     19837       99.9%      54.5% 56.2%   261803    6.28    56.7%    95.3*   -13    0.733   19760  
     3.23      262055   20421     20441       99.9%      71.0% 72.1%   262055    4.81    73.9%    92.0*   -10    0.744   20365  
     3.13      275504   21262     21300       99.8%      86.9% 88.3%   275504    3.91    90.4%    88.6*    -9    0.738   21209  
     3.04      291152   21807     21828       99.9%     110.2% 112.7%   291152    3.17   114.6%    83.4*    -7    0.730   21777  
     2.95      304614   22508     22545       99.8%     135.3% 136.6%   304614    2.59   140.6%    77.2*    -7    0.730   22485  
     2.87      311277   23188     23214       99.9%     166.9% 169.0%   311277    2.05   173.5%    68.2*    -5    0.713   23151  
     2.80      274084   23763     23801       99.8%     201.8% 205.1%   274081    1.52   211.3%    54.1*    -4    0.691   23388  
    total     4192714  320944    321419       99.9%      24.0% 25.5%  4192711    9.61    25.0%    99.6*   -13    0.710  319848  
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6.3 Scripts and parameterization files for structure refinement 
6.3.1 Refinement strategy file for phenix.refine 
phenix.refine \ 
~/merge3/merge3.mtz \ 
~/pol1/build6_5.pdb \ 
strategy=rigid_body+individual_sites+individual_adp+tls \ 
refinement.input.xray_data.r_free_flags.label=FreeR_flag \ 
rigid_bodies.params \ 
ncs_groups.params \ 
tlsmd.params \ 
main.ncs=True ncs.type=cartesian \ 
ncs.find_automatically=False \ 
check_rotamer_consistency=False \ 
disulfide_distance_cutoff=0.5 \ 
adp.convert_to_iso=true \ 
adp.set_b_iso=60 \ 
poli-zinc.restraints \ 
solvent.params \ 
refinement.ncs.excessive_distance_limit=None \ 
main.number_of_macro_cycles=6 
 
6.3.2 Definition of bond lengths for one coordinated Zinc atom 
refinement.geometry_restraints.edits { 
  zn_sg_dist = 2.34 
  sigma_zn_sg_dist = 0.05 
  zn_ne2_dist = 2.00 
  sigma_zn_ne2_dist = 0.02 
  slack = None 
   
  ### Zn A:3001 ### 
  bond { 
    action = *add 
    atom_selection_1 = chain A and resid 3001 and resname  ZN and name ZN 
    atom_selection_2 = chain A and resid   62 and resname CYS and name SG 
    distance_ideal = $zn_sg_dist 
    sigma = $sigma_zn_sg_dist 
    slack = $slack 
  } 
  bond { 
    action = *add 
    atom_selection_1 = chain A and resid 3001 and resname  ZN and name ZN 
    atom_selection_2 = chain A and resid   65 and resname CYS and name SG 
    distance_ideal = $zn_sg_dist 
    sigma = $sigma_zn_sg_dist 
    slack = $slack 
  } 
  bond { 
    action = *add 
    atom_selection_1 = chain A and resid 3001 and resname  ZN and name ZN 
    atom_selection_2 = chain A and resid   72 and resname CYS and name SG 
    distance_ideal = $zn_sg_dist 
    sigma = $sigma_zn_sg_dist 
    slack = $slack 
  } 
  bond { 
    action = *add 
    atom_selection_1 = chain A and resid 3001 and resname  ZN and name ZN 
    atom_selection_2 = chain A and resid   75 and resname HIS and name NE2 
    distance_ideal = $zn_ne2_dist 
    sigma = $sigma_zn_ne2_dist 
    slack = $slack 
  } 
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6.3.3 Definition file for NCS refinement 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 1:84 
  selection = chain P and resseq 1:84 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 85:139 
  selection = chain P and resseq 85:139 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 176:272 
  selection = chain P and resseq 176:272 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 296:363 
  selection = chain P and resseq 296:363 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 364:380 
  selection = chain P and resseq 364:380 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 381:441 
  selection = chain P and resseq 381:441 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 442:477 
  selection = chain P and resseq 442:477 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 478:652 
  selection = chain P and resseq 478:652 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 653:826 
  selection = chain P and resseq 653:826 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 827:989 
  selection = chain P and resseq 827:989 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 990:1028 
  selection = chain P and resseq 990:1028 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 1029:1152 
  selection = chain P and resseq 1029:1152 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 1160:1204 
  selection = chain P and resseq 1160:1204 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 1213:1337 
  selection = chain P and resseq 1213:1337 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 1361:1395 
  selection = chain P and resseq 1361:1395 
} 
refinement.ncs.restraint_group { 
  reference = chain A and resseq 1596:1664 
  selection = chain P and resseq 1596:1664 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 8:79 
  selection = chain Q and resseq 8:79  
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 88:204 
  selection = chain Q and resseq 88:204 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 205:404 
  selection = chain Q and resseq 205:404 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 405:489 
  selection = chain Q and resseq 405:489 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 490:697 
  selection = chain Q and resseq 490:697 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 698:798 
  selection = chain Q and resseq 698:798 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 799:910 
  selection = chain Q and resseq 799:910 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 911:1038 
  selection = chain Q and resseq 911:1038 
} 
refinement.ncs.restraint_group { 
  reference = chain B and resseq 1039:1203 
  selection = chain Q and resseq 1039:1203 
} 
refinement.ncs.restraint_group { 
  reference = chain C and resseq 31:76 
  selection = chain R and resseq 31:76 
} 
refinement.ncs.restraint_group { 
  reference = chain C and resseq 77:220 
  selection = chain R and resseq 77:220 
} 
refinement.ncs.restraint_group { 
  reference = chain C and resseq 221:334 
  selection = chain R and resseq 221:334 
} 
refinement.ncs.restraint_group { 
  reference = chain D 
  selection = chain S 
} 
refinement.ncs.restraint_group { 
  reference = chain G and resseq 14:127 
  selection = chain V and resseq 14:127 
} 
refinement.ncs.restraint_group { 
  reference = chain G and resseq 128:250 
  selection = chain V and resseq 128:250 
} 
refinement.ncs.restraint_group { 
  reference = chain O and resseq 265:315 
  selection = chain 4 and resseq 265:315 
} 
refinement.ncs.restraint_group { 
  reference = chain E and resseq 5:147 
  selection = chain T and resseq 5:147 
} 
refinement.ncs.restraint_group { 
  reference = chain E and resseq 148:215 
  selection = chain T and resseq 148:215 
} 
refinement.ncs.restraint_group { 
  reference = chain F 
  selection = chain U 
} 
refinement.ncs.restraint_group { 
  reference = chain H 
  selection = chain W 
} 
refinement.ncs.restraint_group { 
  reference = chain I and resseq 2:74 
  selection = chain X and resseq 2:74 
} 
refinement.ncs.restraint_group { 
  reference = chain I and resseq 75:125 
  selection = chain X and resseq 75:125 
} 
refinement.ncs.restraint_group { 
  reference = chain J 
  selection = chain Y 
} 
refinement.ncs.restraint_group { 
  reference = chain K 
  selection = chain Z 
} 
refinement.ncs.restraint_group { 
  reference = chain L 
  selection = chain 1 
} 
refinement.ncs.restraint_group { 
  reference = chain M 
  selection = chain 2 
} 
refinement.ncs.restraint_group { 
  reference = chain N and resseq 22:140 
  selection = chain 3 and resseq 22:140 
} 
refinement.ncs.restraint_group { 
  reference = chain N and resseq 141:180 
  selection = chain 3 and resseq 141:180 
} 
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6.3.4 Definition file for Rigid body refinement 
refinement.refine.sites { 
 
rigid_body = chain A and resseq 1:84 
rigid_body = chain A and resseq 85:139  
rigid_body = chain A and resseq 176:272 
rigid_body = chain A and resseq 296:363 
rigid_body = chain A and resseq 364:380 
rigid_body = chain A and resseq 381:441 
rigid_body = chain A and resseq 442:477 
rigid_body = chain A and resseq 478:652 
rigid_body = chain A and resseq 653:826 
rigid_body = chain A and resseq 827:989 
rigid_body = chain A and resseq 990:1028 
rigid_body = chain A and resseq 1029:1152 
rigid_body = chain A and resseq 1160:1204 
rigid_body = chain A and resseq 1213:1350 
rigid_body = chain A and resseq 1362:1395 
rigid_body = chain A and resseq 1440:1543 
rigid_body = chain A and resseq 1544:1595 
rigid_body = chain A and resseq 1596:1664 
rigid_body = chain B and resseq 8:79 
rigid_body = chain B and resseq 88:204 
rigid_body = chain B and resseq 205:404 
rigid_body = chain B and resseq 405:489 
rigid_body = chain B and resseq 490:697 
rigid_body = chain B and resseq 698:798 
rigid_body = chain B and resseq 799:910 
rigid_body = chain B and resseq 911:1038 
rigid_body = chain B and resseq 1039:1203 
rigid_body = chain C and resseq 31:76 
rigid_body = chain C and resseq 77:220 
rigid_body = chain C and resseq 221:334 
rigid_body = chain G and resseq 14:127 
rigid_body = chain G and resseq 128:250 
rigid_body = chain E and resseq 5:147 
rigid_body = chain E and resseq 148:215 
rigid_body = chain F  
rigid_body = chain D  
rigid_body = chain H  
rigid_body = chain I and resseq 2:74 
rigid_body = chain I and resseq 75:125 
rigid_body = chain J  
rigid_body = chain K  
rigid_body = chain L 
rigid_body = chain M 
rigid_body = chain N and resseq 22:140 
rigid_body = chain N and resseq 141:180 
rigid_body = chain O 
rigid_body = chain P and resseq 1:84 
rigid_body = chain P and resseq 85:139  
rigid_body = chain P and resseq 176:272 
rigid_body = chain P and resseq 296:363 
rigid_body = chain P and resseq 364:380 
rigid_body = chain P and resseq 381:441 
rigid_body = chain P and resseq 442:477 
rigid_body = chain P and resseq 478:652 
rigid_body = chain P and resseq 653:826 
rigid_body = chain P and resseq 827:989 
rigid_body = chain P and resseq 990:1028 
rigid_body = chain P and resseq 1029:1152 
rigid_body = chain P and resseq 1160:1204 
rigid_body = chain P and resseq 1213:1350 
rigid_body = chain P and resseq 1362:1395 
rigid_body = chain P and resseq 1440:1543 
rigid_body = chain P and resseq 1544:1595 
rigid_body = chain P and resseq 1596:1664 
rigid_body = chain Q and resseq 8:79 
rigid_body = chain Q and resseq 88:204 
rigid_body = chain Q and resseq 205:404 
rigid_body = chain Q and resseq 405:489 
rigid_body = chain Q and resseq 490:697 
rigid_body = chain Q and resseq 698:798 
rigid_body = chain Q and resseq 799:910 
rigid_body = chain Q and resseq 911:1038 
rigid_body = chain Q and resseq 1039:1203 
rigid_body = chain R and resseq 31:76 
rigid_body = chain R and resseq 77:220 
rigid_body = chain R and resseq 221:334 
rigid_body = chain V and resseq 14:127 
rigid_body = chain V and resseq 128:250 
rigid_body = chain T and resseq 5:147 
rigid_body = chain T and resseq 148:215 
rigid_body = chain U  
rigid_body = chain S  
rigid_body = chain W  
rigid_body = chain X and resseq 2:74 
rigid_body = chain X and resseq 75:125 
rigid_body = chain Y  
rigid_body = chain Z  
rigid_body = chain 1 
rigid_body = chain 2 
rigid_body = chain 3 and resseq 22:140 
rigid_body = chain 3 and resseq 141:180 
rigid_body = chain 4 
} 
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6.3.5 Definition file for TLS refinement 
refinement.refine.adp { 
 
    tls = chain A and (resid 654:1013 or resid 1361:1367) or \ 
          chain B and (resid 8:209 or resid 400:553 or resid 647:1068) or \ 
          chain C or \ 
          chain J or \ 
          chain K or \ 
          chain L or \ 
          chain N and resid 147:180 
    tls = chain A and (resid 477:653 or resid 1014:1261 or resid 1368:1395 or resid 1500:1608) or \ 
          chain B and resid 1069:1092 or \ 
          chain E or \ 
          chain F and resid 73:154 
    tls = chain A and (resid 1:476 or resid 1609:1649 or resid 3001:3002) or \ 
          chain B and (resid 1093-1203 or resid 3001) or \ 
          chain O 
    tls = chain A and resid 1650:1664 or \ 
          chain D or \ 
          chain F and resid 55:72 or \ 
          chain G 
    tls = chain M or \ 
          chain N and resid 25:146 
    tls = chain I and (resid 2:52 or resid 3001) 
    tls = chain I and resid 53:78 
    tls = chain I and (resid 79:125 or resid 3002) 
    tls = chain A and (resid 1262:1337 or resid 1440:1499) 
    tls = chain B and resid 210:399 
    tls = chain B and resid 554:646 
    tls = chain H 
    tls = chain P and (resid 654:1013 or resid 1361:1367) or \ 
          chain Q and (resid 8:209 or resid 400:553 or resid 647:1068) or \ 
          chain R or \ 
          chain Y or \ 
          chain Z or \ 
          chain 1 or \ 
          chain 3 and resid 147:181 
    tls = chain P and (resid 477:653 or resid 1014:1261 or resid 1368:1395 or resid 1500:1608) or \ 
          chain Q and resid 1069:1092 or \ 
          chain T or \ 
          chain U and resid 73:154 
    tls = chain P and (resid 1:476 or resid 1609:1649 or resid 3001:3002) or \ 
          chain Q and (resid 1093-1203 or resid 3001) or \ 
          chain 4 
    tls = chain P and resid 1650:1664 or \ 
          chain S or \ 
          chain U and resid 55:72 or \ 
          chain V 
    tls = chain 2 or \ 
          chain 3 and resid 25:146 
    tls = chain X and (resid 2:52 or resid 3001) 
    tls = chain X and resid 53:78 
    tls = chain X and (resid 79:125 or resid 3002) 
    tls = chain P and (resid 1262:1337 or resid 1440:1499) 
    tls = chain Q and resid 210:399 
    tls = chain Q and resid 554:646 
    tls = chain W 
  } 
6.3.6 Solvent definition file for refinement 
refinement { 
 
  main.ordered_solvent = True 
 
  ordered_solvent { 
    # reduce resolution limit to allow ordered solvent below 2.8 A 
    low_resolution = 2.9 
    mode = every_macro_cycle 
    output_chain_id = w 
    # more reasonable minimum and maximum hydrogen bond distances 
    h_bond_min_mac = 2.2 
    h_bond_min_sol = 2.2 
    h_bond_max = 3.5 
    b_iso_min = 1.0 
    b_iso_max = 70.0 
    # B-factor for new water molecules; if not set, the mean B-factor is used 
    b_iso = 50.0 
    primary_map_type = mFobs-DFmodel 
    primary_map_cutoff = 3.0 
    secondary_map_and_map_cc_filter { 
      cc_map_2_type = 2mFobs-DFmodel 
      poor_cc_threshold = 0.7 
      poor_map_value_threshold = 1.0 
    } 
  } 
} 
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6.4 Structure-based alignment of A190 and Rpb1 
 
Figure 32. Structure-based alignment of A190 and Rpb1. 
Invariant and conserved residues are highlighted in green and light green, respectively. Secondary structure 
elements are indicated above and below the alignment for A190 and Rpb1, respectively (cylinders, helices; 
arrows, strands). Residues that form different folds in Pol I or form Pol-II-specific folds are in green or red, 
respectively (compare Figure 13 and Figure 14). 
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6.5 Structure-based alignment of A135 and Rpb2 
 
Figure 33. Structure-based alignment of A135 and Rpb2. 
Invariant and conserved residues are highlighted in green and light green, respectively. Secondary structure 
elements are indicated above and below the alignment for A135 and Rpb2, respectively (cylinders, helices; 
arrows, strands). Residues that form different folds in Pol I or form Pol-II-specific folds are in green or red, 
respectively (compare Figure 13 and Figure 14). 
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6.6 Structure-based alignment of AC40/AC19 and the Rpb3/Rpb11 subcomplex  
 
Figure 34. Structure-based sequence alignment of the sub complex AC40/AC19 with Rpb3/Rpb11. 
Structure-based alignment of AC40 and Rpb3 (a) and of AC19 and Rpb11 (b). Invariant and conserved residues 
are highlighted in green and light green, respectively. Secondary structure elements are indicated above and 
below the alignment for AC40 and Rpb3, respectively (cylinders, helices; arrows, strands). Residues that form 
different folds in Pol I or form Pol-II-specific folds are in green or red, respectively (compare Figure 13 and 
Figure 15). 
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6.7 Conservation of Pol I and Pol II subunits 
According to the presented structure-based sequence alignments and a previously published 
one8, the identity between subunits of Pol I and Pol II was re-evaluated. A new (and for the 
first time structurally founded) table of identities was prepared (Table 16). 
 
 
Table 16. Subunits of the three S. cerevisiae RNA 
polymerases with Sequence identity inferred from 
structure-based sequence alignments 
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6.8 Domain differences between the polymerase subunits A190/Rpb1 and A135/Rpb2 
 
 
Figure 35. Detailed comparison of A190–A135 domains with their Rpb1–Rpb2 counterparts. 
a Comparison of A190 domain structures (top) that differ significantly from their corresponding Pol II regions 
(bottom). Labelling of corresponding secondary structure elements is as for Pol II58. New or lacking secondary 
structure elements are labelled. New elements were named according to the preceding Pol II element with small 
letters added alphabetically for subsequent elements. b Comparison of A135 domain structures (top) that differ 
significantly from their corresponding Pol II regions (bottom). 
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6.9 Evolutionary conservation of expander and connector elements 
 
 
 
Figure 36. Sequence conservation of the expander and the connector element. 
a Amino acid sequence alignment of the connector region in S. cerevisiae (Sc); Candida glabrata (Cg); Homo 
sapiens (Hs) and Mus musculus (Mm). Secondary structure elements are indicated above the alignment (K5 
helix, cylinder; strands D1, D2; arrows). Residues that are involved in the interface with the Pol I clamp and cleft 
and showed a buried surface area in excess of 40Å² are indicated with an asterisk above the alignment. Buried 
surfaces were calculated with the PISA server124. A structure-based alignment of the A14–A43 stalk residues 
was published8,61 and is not included here. b Amino acid sequence alignment of the expander region in S. 
cerevisiae, C. glabrata, H. sapiens and M. musculus. Secondary structure elements are indicated above the 
alignment (helices, cylinders; strands, arrows). Residues that are involved in the interface with the Pol I cleft and 
showed a buried surface area in excess of 40Å² are indicated with an asterisk above the alignment. Buried 
surfaces were calculated with the PISA server124. 
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6.10 Expander mutations do not display a growth defect in S. cerevisiae on YPD medium 
 
Figure 37. Mutation of the expander element does not result in a growth defect on YPD medium. 
The expander element was mutated at different positions. None of them exhibited an obvious growth defect. If 
repeated at 30°C, 37°C or under stress conditions, no effect took place as well (data not shown). 
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7. Abbreviations
°C Degree celsius 
FAM 6-carboxy-fluoresceine 
Å Ångstrom 
Amp Ampicillin 
AU asymmetric unit 
Bp base pairs 
Cam Chloramphenicol 
CE Core element 
CF Core factor 
CV Column volume 
DSS Di-succimidyl suberate 
DTT Dithiothreitol 
EM Electron microscopy 
ESRF European Synchrotron Radiation Facility 
g g-force 
G418 Geneticin 
h  hours 
HRP Horseradish peroxidase 
IGS Intergenic space 
Kan Kanamycin 
LB Luria-Bertani medium 
MAD Multi-wavelength anomalous diffraction 
min minutes 
NCS Non-crystallographic symmetry 
Nl normal litres 
NOR Nucleolar organizer region 
NTP Nucleoside triphosphate 
OD600 Optical density at 600nm 
PAGE Polyacrylamide gel electrophoresis 
PDB Protein Data Bank 
PEG Polyethylen glycol 
PI Protease inhibitor mix 
PIC Pre initiation complex 
Pol RNA polymerase 
rmsd root mean square deviation 
RNAP RNA polymerase 
RT Room temperature 
s seconds 
SAD Single-wavelength anomalous 
diffraction 
SEC Size exclusion chromatography 
SDS Sodium-Dodecyl-Sulphate 
SLS Swiss Light Source 
Strep Streptamycin 
TCA Trichloroacetric acid 
TCEP Tris(2-carboxyethyl)phosphine 
Tet Tetracyclin 
TOR Target of rapamycin 
TPB TATA-binding protein 
UAF Upstream activating factor 
UE Upstream element 
v/v Volume per volume 
w/v Weight per volume 
YPD Yeast extract peptone dextrose 
medium 
